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A STUDY ON URINARY BACTERIAL AND FUNGAL ISOLATES 
AND THEIR ANTIMICROBIAL SUSCEPTIBILITY PATTERN 
FROM PATIENTS UNDERGOING INVASIVE UROLOGICAL OP 
DIAGNOSTIC PROCEDURES INCLUDING CYSTOSCOPY AND 
URODYNAMIC STUDY 
ABSTRACT 
Objectives. To isolate and identify the bacterial and fungal causative agents for 
post procedure of urinary tract infection in patients undergoing cystoscopyand 
urodynamic (UD) evaluation in a prospective survey. To study the association of 
ompT virulent gene for E.coli with significant colony counts. The tolerability and 
acceptance of  and UD studies by patients have not been thoroughly documented. 
It would be helpful to be able to give such information to patients before 
performing these procedures. 
Methods. A total of 200 patients seen as outpatients for Cystoscopy and 
Urodynamic studies to evaluate various indications were studied. A midstream 
urine sample was taken before,third day and seventh after the procedures and 
semiquantitative culture was employed for colony counts. Detection of virulent 
gene ompT for E.coli by conventional PCR.   Patients were given a questionnaire 
that inquired about the presence of lower urinary tract symptoms after the 
procedures.  
Results. Of the 200 patients analyzed (Cystoscopy100, UD studies 100), 9 patients 
(4.5%) developed significant bacteriuria .E.coli (40.9%) was the commonest 
isolated organism.ompT gene was negative for E.coli with significant colony 
counts. Only 2 patients(2%) with significant bacteriuria  symptoms . The 
association between patients who had symptoms with significant growth and 
underlying condition after the procedure (n = 2) was significant (P<0.05). ompT 
gene 
Conclusions.Cystoscopy and Urodynamic studies are safe, well-tolerated 
procedures. The antibiotics for the transieint infection of  these procedures is 
unnecessary, unless specific indications are present. 
Key words- ompT-outer membrane protein, PCR-polymerase chain reaction 
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INTRODUCTION 
 
 Various diagnostic, therapeutic procedures are carried out as OP 
procedures in hospitals for evaluation of urinary tract infection. Intervention of 
urinary tract by various catheters, guidewires, stents, endoscopes and 
associated instrumentation is required for diagnostic, therapeutic purposes or 
both. Both the Urodynamic procedure and Cystoscopy are employed as OP 
diagnostic procedure for variety of reasons in urology care settings. Physicians 
should be familiar with the proposed instrumentation and they should make the 
patients aware of the procedure and its complications. 
 
 Cystoscopy is an invasive procedure and the most commonly performed 
investigation in urology to monitor, diagnose and treat conditions affecting 
urethra and bladder. As a diagnostic outpatient investigation cystoscopy is 
incorporated firmly and widely performed for various urological diseases such 
as haematuria, symptoms associated with lower urinary tract and surveillance 
of bladder cancer following resection of tumour and radiation therapy. 
 
 Though traditionally considered as a clean procedure it is associated 
with marked morbidity [4] and risk of complications including bleeding, 
infection and pain. Despite the relative low rate of UTI there remain a number 
of patients requiring parenteral antibiotics for complicated UTI. And also it has 
the risk of outbreaks of infection due to organisms including Pseudomonas 
aeruginosa, secondary to scope contamination and processing failures [5]. 
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 Urodynamics is the dynamic study of the storage, transport and 
evacuation of the urinary tract. This procedure is performed for disorders of 
lower urinary tract mainly in patients with incontinence and forms an 
important part of evaluation of neuropathic disorders in neuro urology and in 
female geriatric patients involving urinary tract. Selecting a patient for surgery 
based on history, physical examination, endoscopy or radiographic findings 
would be inappropriate. So further altered physiology of urinary tract must be 
investigated by urodynamic tests to devise an appropriate surgery for the 
patients. 
 
 Catheters are employed for urodynamic evaluation. It is a mild invasive 
procedure. Catheters are the tools that destroy the host immune system and let 
microorganisms to enter normally under aseptic conditions [6, 7]. Adequate 
lubrication is very important than sterility before insertion of catheter. 
Urodynamic studies are associated with an increased risk of bacteriuria and 
symptomatic urinary tract infection (UTI) because it is applied by 
catheterization [9].  
 
 There is no thorough documentation of acceptance and tolerability of 
these two procedures by the patients. Cystoscopy and Urodynamic study has a 
risk of infection and this should be taken into account. It should be included in 
counselling for the patients undergoing these procedures as a part of good 
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clinical practice. Patients were requested to collect midstream urine [ MSU ] 
sample to the microbiology laboratory  at the time of procedure , third day and 
seventh  after the  procedure.  
 
 Infection is the recognized complication of instrumentation in the lower 
urinary tract [1]. Infection of one or more structures in the urinary system is 
called as UTI. The most common site of nosocomial infections is the urinary 
tract. Catheterization and instrumentation are the major predisposing factors 
for UTI [2].Wide range of UTIs have been reported after lower urinary tract 
invasive procedures [1]. Invasive urological procedures account for up to 10 % 
of the nosocomial infections [3]. 
 
 Active screening for UTI before these two procedures to avoid 
inappropriate intervention based on false-positive study [12]. Urine samples 
were collected under strict aseptic precautions and processed without delay. 
Defining the CFU/ml that represents clinically significant infection can be 
difficult. Colony counts were determined by semi-quantitative culture of the 
urine to determine whether it contains a potentially pathogenic bacteria in 
numbers sufficient to identify it as the causal infecting organism. Significance 
of the colony counts were interpreted in relation to the clinical information of 
the patient [10].  
  
 
 
 
 
Aims and Objectives 
of the study 
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AIMS AND OBJECTIVES 
 
1. To isolate and identify the bacterial & fungal causative agents for post 
invasive procedure of urinary tract infection in patients undergoing 
Cystoscopy and Urodynamic procedure. 
2. To perform semi-quantitative count and to define the urinary tract 
infection. 
3. To study the association of significant bacteriuria and candiduria 
separately withCystoscopy and Urodynamic procedure. 
4. To study the antibacterial &antifungal susceptibility pattern for the 
isolates. 
5. To study the association of virulent gene (ompT) in E.coli with 
significant colony counts as it is commonest isolate in causing urinary 
tract infection after post cystoscopy and urodynamic study. 
6. To compare and evaluate relative merits of each of these invasive 
procedures as OP urological investigation procedure. 
  
 
 
 
 
Review of literature 
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REVIEW OF LITERATURE 
 Manipulation of urinary tract by various instruments such as  
urethroscopes, rectoscopes, cystoscopes and various catheters were used in 
urology care setting for various therapeutic, diagnostic purposes or both. These 
instruments were used to manipulate the urinary tract in retrograde manner 
without the need to open through surgery. This feature differentiates urology 
and other clinical fields. Care should be taken while applying these 
instruments over the patients since it can cause significant injury while 
manipulating the urinary tract. Physician should understand the procedure, its 
limitations and sterile precautions which includes preparing patients before the 
procedure, sterile irrigating solutions and sterilizing instruments 
usedinbetween the patients. 
 
NORMAL FLORA  
 Many micro-organisms are located in the urethra and vulva, and 
contaminate the urine in its passage, so that normally freshly voided urine is 
never sterile, but always contain a certain number of bacteria, some of them 
simple and harmless and others of them are dangerous and pathogenic. These 
organisms find their way into the bladder from the urethra, usually by the 
passage of instruments, or by creeping along the short and wide urethra of the 
female [14]. 
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 Anaerobic bacteria, Lactobacilli, Corynebacteria, Streptococci (not 
including Enterococci), and Staphylococcusepidermidis are found in normal 
periurethral flora. They do not commonly cause UTIs in healthy individuals 
and are considered common urinary contaminants [14]. 
 
PATHOGENESIS [13] 
ANTIBACTERIAL HOST DEFENCES IN THE URINARY TRACT 
 Antibacterial substances such as flushing action of urine, urinary pH, 
presence of organic acids, bactericidal activity of urine, inhibitors of adherence 
of bacteria  present in the host protects from bacterial infection. While 
inserting the catheter, or any instruments involving retrograde manipulation of 
urinary tract for diagnostic, therapeutic purposes or both it may carry the 
organisms present in the urethra into the bladder and cause infection even after 
following strict aseptic precaution. The incidence of bacteriuria ranging from 
about 1% and 20 % in healthy and elderly hospitalized patients respectively. 
[16,17]. 
   Among the three pathways the ascending, hematogenous, and lymphatic 
pathways ascending pathway of infection is the most important. UTI is more 
common in women than in men gives support to the importance of the 
ascending route of infection. Contamination is more in females than males 
since the female urethra is short and proximal in position to the vulvar and 
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perineal areas. Colonization of organisms takes place in women before urinary 
infection results.   
 
UROVIRULENCE IN BACTERIA 
 Among the urinary pathogens E.coli  is the most commonest 
uropathogen particularly O, K, and H serogroups. These particular serogroups 
are capable of adhering to uroepithelium by means of  P pili and type 1 pili.  
Once attachment to uroepithelial cells occurs, other bacterial pathogenic 
factors such as hemolysin, which initiates tissue invasion and makes iron 
available for the infecting pathogens and cause infection of urinary tract. the 
presence of K antigen on the invading bacteria protects them from 
phagocytosis. The K antigen present in the pathogens  allow the infecting 
pathogens to escape the various host defenses. 
 
 In addition to above factors there are many virulent genes associated 
with uropathoenic strains. They are ompT , CNF1, adhesins, iha and hlya. 
ompT gene is a house keeping gene protease present in most outer membrane 
of  Gram negative bacteria that degrades foreign peptide in the surrounding 
environment and it is associated with pathogenesis in urinary tract infection, 
intestinal colonization and sepsis. 
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CAUSATIVE PATHOGENS 
 E.coli causes80 % of the uncomplicated urinary tract infection (Orskov 
et al). Klebsiellaspp, Proteus spp, Enterobacter spp. Pseudomonasspp and 
Staphylococcus sppandEnterococci are other uropathogens causing hospital – 
acquired UTIs (Wagnenlehner and Naber, 2000). Staphylococcus 
saprophyticus, once often thought as urinary contaminants, can cause 
uncomplicated UTI in young women. (Hovelius and Mardh, 1984).  
 
EPIDEMIOLOGY OF URINARY TRACT INFECTION 
 More than 95 % of UTIs are caused by a single bacterial species. In 
acute infectionE.coli is the most common causeofinfection[19, 20]. Infection 
caused by Proteus, Pseudomonas, Klebsiella, Enterococci sppand 
Staphylococci increases greatly in patients with structural abnormalities 
because of instrumentation and repeated courses of antimicrobial therapy.  
 
 Fungi particularly candida species occur in patients with indwelling 
catheter.  The prevalence of bacteriuria in young women is about 1% to 3% 
and adult men is  1%[21]is lowcompared to 10 % in older men and 20% in older 
women. During their life time of women experience 40 to 50% of symptomatic 
UTI[22, 23]. Neuro muscular diseases, increased instrumentation and bladder 
catheter usage in both genders [24] are possible reasons in older patients .  
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URODYNAMIC STUDY 
HISTORY [26,27] 
 Davis in the year 1954 coined the term urodynamics though instruments 
for bladder pressure measurement and rate urine flow has been developed in 
the year 1800s itself(Davis 1954; Perez and Webster 1992). 
 
 Measuring the various pressures is the most important part of 
urodynamic study.The year 1950 is the infant period of modern 
urodynamics.VonGarrelts' and Davis published work on  measurements of 
uroflowmetry and cystometry pressures simultaneously inspired a lot (Perez 
and Webster 1992).Von Garretin the year 1956 and in 1963Zinner and 
Paquinreported the normal micturition pressures electronically in men and in 
women (Zinner and Paquin 1963) respectively.  
 
 Following them in 1960 reintroduction ofmeasurement of micturition 
pressures by Murphy and Schoenberg  and  in 1962 combination use 
ofcystometry and uroflowmetryby Gleason and Lattimerfor  bladder outlet 
strictures  was called as the pressure-flow study (Gleason and 
Lattimer1962).The achievement of these basic researchdrew back the prologue 
of modern urodynamic studies[28]. 
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 Urodynamic studies provides valuable information regarding etiology 
and act in concert with clinical history and physical examination of the patient 
for appropriate intervention. 
 
INDICATIONS  
1. To identify or to rule out the factors contributing to the incontinence and 
their relative importance 
2. To obtain information about other aspects of the lower urinary tract 
dysfunction 
3. To predict the consequences of the dysfunction for the upper urinary 
tract 
4. To predict the outcome and undesirable side effects of a contemplated 
treatment. 
5. To confirm the effects of treatment or to understand the mode of action 
of a particular type of treatment, especially a new one. 
6. To understand the reasons for failure of previous treatments for 
incontinence 
 
SAFETY 
 Screening of urine for bacteriuria at the time of the testes important to 
rule out unrecognized infection. Antibiotics administered at or just after the 
study, are at thediscretion of the investigator. The main risks of cystometry are 
those associated with urethral catheterization. Dysuria (painful voiding) occurs 
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in some patients after urodynamic testing, but usually disappears within 48 
hour. The technique used for catheterization, and for handling of transducers 
and connecting tubes, varies in different centers from clean to sterile. It is not 
known whether these variations have any effect on the infection rates. In any 
case, appropriate aseptic techniques should be used. 
 
URODYNAMIC PROCEDURE 
TECHNIQUE 
 Patients were asked to attend for their investigations with a full urinary 
bladder.  The urinary flow rate was initially measured and the patients were 
encouraged to empty their bladder completely.The vulva and external urethral 
meatus were washed with sterile aqueous solution containing chlorhexidine 
gluconate 0.015% w/v and cetrimide 0.15% w/v. After adequate lubrication 
with a sterile lubricating gel, the bladder pressure catheter (4.5 F) was inserted 
above and alongside the bladder-filling catheter (10 F).  
 
 The post void residual volume (PVR) was then collected by 
catheterization, and a catheter specimen of urine obtained at this time and sent 
for bacteriological assessment. Both catheters were taped in place, care being 
taken to avoid blockage of the bladder pressure catheter.  
 
 A rectal balloon catheter (4.5 F) with a perforated latex sheath (to avoid 
fecal plugging) was similarly introduced into the rectum to measure the intra-
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abdominal pressure. The bladder-filling catheter was then connected to the 
filling tube and pump. The bladder and rectal pressure catheters were 
connected to the bladder and rectal external transducers, respectively, by 
proximal extension tubes filled with sterile normal saline. These proximal 
tubes were regularly replaced between patients to minimize the chances of 
cross-infection. 
 
 Urodynamic studies were carried out according to standard criteria [33] in 
the erect position with an Albyn Medical (Griffon, UK) urodynamic unit and a 
multichannel recorder. The bladder was filled at 100 mL/min with sterile 
normal saline at room temperature until either 500 mL had been infused, or 
unstable detrusor activity or patient discomfort precluded further filling.  
 
 On completing the filling cystometry, all catheters were withdrawn and 
the uroflowmetry repeated. Patients were usually encouraged to void to 
completion, after which the PVR was assessed by simple subtraction (voided 
volume from infused volume) and if thought significant, evaluated further with 
ultrasonography. 
 
Disinfection of catheters 
Cidex (2% glutaraldehyde) 
 It is a high-level disinfectant for heat-sensitive reusable medical devices 
that cannot undergo sterilization. Most commonly used disinfectant for 
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medical devices.Catheters used in the urodynamic procedure were disinfected 
by 2% glutraldehyde solution for 30 minutes before starting the procedure, in 
between the patients and air dried before storage. 
 
RISK ASSOCIATED WITH URODYNAMIC TESTING 
SIDE EFFECTS 
 discomfort in the area where a catheter was put in – this get better 
after a few hours 
 mild stinging when  passing urine 
 blood in  urine 
 Urinary tract infection infection 
 
CYSTOSCOPY 
HISTORY [34] 
 The cystoscope which is used nowadays is the outcome of many 
centuries of development.In the year 1805 Bozinni’s introduced the protype of 
urethral viewing tube. These protypesweredifficult to use for the operator, 
caused patient inconvenience and it is dangerous for both. 
 
 The images were inverted and backwardsby early models and needed 
the skill of operator to correct this image. Objects appeared small and distant 
since it is illuminated by reflected candlelight. With the advanced Nitze’s 
prototype, a forerunner of the current cystoscope which utilizes lenses, prisms 
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and the incandescent light  image quality was improved.Cystoscopehas  
broadened the scope of urology since its introduction. 
 
 Image quality,educational opportunities and quality of patient care was 
unparralled with the invention of fibre optics and digital imaging 
unimaginableto the early pioneers.  
 
Cystoscopy can assist in identifying problems with the urinary tract, 
such as early signs of cancer, infection, strictures (narrowing), obstruction, and 
bleeding. Cystoscopy is an endoscopic technique for examining the internal 
aspect of the bladder. It is the principle way to diagnose and surveil bladder 
conditions.  
 
Indications to perform cystoscopy   
 Cystoscopy can be used for diagnostic and operative indications. It is 
being used in gynecologic and non-gynecologic conditions [35,36] 
 
 Identifying intraoperative injuries gynecologic malignancies 
involving urinary tract 
 Genitourinary fistulas 
 Traumatic involvement of the urinary tract 
 Irritative voiding symptoms in the absence of urinary tract 
infection (urinary urgency or frequency or urge incontinence) 
 Urethral diverticulum 
 Verification of suprapubic catheter placement 
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Indications to perform cystoscopy for non-gynecologic conditions: 
 Recurrent urinary tract infections 
 Hematuria 
 Urinary incontinence or overactive bladder 
 Abnormal urine cytology 
 Chronic pelvic pain, interstitial cystitis and painful urination 
 Urinary blockage caused by stricture, or narrowing of the urinary 
tract 
 Stone, unusual growth, polyp, tumor, or cancer in the urinary tract 
 
Types of Cystoscopy 
 Based on flexibility and type of anaesthesiaused there are two main 
types of cystoscopy - flexible and rigid . In flexible cystoscopy, the diameter is 
usually 15 to 18 French. The fiber optic telescope and irrigation channel are 
combined in a single unit.[37] 
 
Differences between rigid and flexible cystoscope 
                Use of flexible fiberopticcystoscopes is associated with less pain and 
postoperative morbidity than rigid cystoscopies [38]. However, the flow rate of 
irrigation fluid is less than with rigid cystoscope and visualization is not as 
clear. Use of a flexible cystoscope requires more extensive training than a rigid 
scope. Use of flexible cystoscopes where no anesthesia, topical anesthetic or 
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conscious sedation is used and rigid cystoscopes where regional or general 
anesthesia is used. 
 
Procedure 
 It can be performed either in OP set up or in operating room. Patient is 
positioned in dorsal lithotomy position and areas weresteriely 
prepared.Cystoscope — A rigid cystoscope consists of a telescope, bridge 
connector, sheath, and obturator (fits inside the sheath) [37]is inserted into the 
urethra and advanced in to the blader.A 30 or 70 degree telescope is usually 
used for cystoscopy, whereas 0 degree lens is preferred for urethroscopy. The 
0 and 12 degrees lenses focuses largely straight ahead and are excellent to 
evaluate the urethra, but often times are inadequate for visualization of the 
entire bladder [39, 40]. 
 
 The 30-degree lens allows optimal visualization of the posterior wall 
and the base of the bladder. The 70-degree lens allows visualization of the 
dome, anterolateral walls, and into an elevated urethrovesical junction, such as 
after colposuspension procedures. Finally, the 120-degree retro-lens allows the 
visualization of the bladder and the urethra, and optimizes visualization of the 
bladder neck [39, 40]. 
 
 The sheath contains channels for instilling irrigation fluid and inserting 
operative instruments. The diameter of the sheath that is used commonly is 17 
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to 24 French. It is advised to use the smallest cystoscope that allows good 
visualization and to minimize pain and trauma to urethra. In selected cases, 
such as urethral compression by a tumor, using a pediatric cystoscope (8 
French) may be helpful [41]. At times, even with the smallest scope, Urethral 
dilatation is necessary. Gradual dilatation using Hegar dilators may be done. [39, 
40]. 
 
 Telescope cables, which are either fibroptic or fluid-filled, serve as the 
illuminating system [39, 40].even though the fluid-filled cables tend to last 
longer, the fibroptic cables are being used more commonly because they are 
less expensive. 
 
Distending medium 
 Irrigating fluid is instilled to distend the bladder and improve 
visualization. There are different distending media conductive fluids (laclated 
ringer’s, normal saline), nonconductive or non-electrolyte (sterile water, 5% 
glycine, 3% sorbitol, 5% mannitol), and gas. The usual distending medium for 
most surgeons for diagnostic procedures is isotonic saline or sterile water, 
because of better visualization.  
 
          Use of any distending medium requires monitoring of fluid absorption to 
avoid volume overload. Use of nonconductive fluids (eg, glycine) may result 
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in hyponatremia, and therefore, these fluids are reserved for operative 
procedures.  
 
Examination of the lower urinary tract using cystoscope 
 Urethra —The urethral mucosa must be examined for pallor, exudates, 
polyps, erythema, condylomata, or diverticulae[37]. 
 
 Bladder —The dome of the bladder can often be identified by the 
presence of an air bubble. Slight suprapubic pressure can facilitate 
visualization of the dome. 
 
 A bubble-like appearance to the trigone, or bullous edema, may indicate 
tumor encroaching upon the bladder, but does not document bladder invasion 
for staging purposes. Frond-like papillary growths or shaggy, necrotic tissue 
may be a tumor (either primary or extending into the bladder) and should be 
biopsied. A biopsy is performed with a cystoscopic biopsy instrument. After 
the biopsy, the biopsy site usually has no bleeding or minimal bleeding that 
does not require cautery. 
 
 Ureteral orifices — the trigone is directly in front of the urethra and is 
identified by locating the interureteric ridge. The cystoscope may need to be 
rotated to visualize the ureteral orifices. Several minutes of observation may be 
needed to identify the orifices, which are small, slit-like openings that only 
become apparent when a burst of urine is released. Use of any distending 
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medium requires monitoring of fluid absorption to avoid volume overload. It is 
important to mention that hyponatremia can happen following use of 
nonconductive irrigation solution. 
 
Reasons for the Procedure 
 A cystoscopy may be recommended when a disorder of the urinary tract 
is suspected. Urinary tract disorders may include structural problems that can 
lead to a blockage of urine flow or a back flow of urine. If untreated, structural 
problems may lead to potentially serious complications. Cystoscopy may also 
be performed after gynecologic surgical procedures near the bladder to check 
for proper placement of sutures and support devices. 
 
Sterility of instruments 
Cidex (2% glutaraldehyde) 
 It is a high-level disinfectant for heat-sensitive reusable medical devices 
that cannot undergo sterilization. Most commonly used disinfectant for 
medical devices. Cystoscopes require a systematic process to be reusable 
which  includesprecleaning, leak testing, cleaning, disinfection with 2%  
glutraldehyde solution (Cidex) for 30 minutes, rinsing, and drying before 
allowing for storage. 
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Risks of the Procedure 
 Bleeding  
 Retention of urine 
 Perforation of bladder 
 Infection  
 
LABORATORY DIAGNOSIS [42] 
SPECIMEN COLLECTION 
 For the laboratory diagnosis of UTI proper collection of urine sample is 
essential. An important consideration of a clinically relevant urine specimen is 
without the contamination of normal perineal, vaginal and anterior urethral 
flora. For the collection of urine sample different methods have been employed 
which are as follows; 
 
CLEAN CATCH MIDSTREAM URINE 
 The most common technique for the collection of urine samples is the 
midstream flow by the clean catch technique. The perineum and periurethral 
area was first cleaned with soapy water followed by the rinse with the sterile 
saline or water. 
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WOMEN 
 During voidingthe labia should be held apart. To flush out bacteria from 
the urethrathe first few millilitres of urine is passed and then midstream urineis 
collected in a sterile wide mouthed container with tightly covered with lid. 
 
MEN 
 Immediately before voidingcleanising of the urethral meatus and then  
midstream urine is collected is usually sufficient [43] . 
 
STRAIGHT CATHETERIZED URINE 
 Employed for the patients who are unable to void urine sample by 
midstream clean catch technique. By this method bladder urine is collected 
with reduced urethral contamination by discarding few millimetres of urine 
coming out from the catheter. Catheterization for this purpose is no longer 
considered justifiable .The main drawback of this method is that it carries risk 
of introducing and initiating infection. 
 
SUPRAPUBIC ASPIRATION  
 With strict aseptic precautions the procedure is done when the bladder is 
full. This method of urine sample collection is reserved for children and 
neonates. By this method contamination of the distal urethra is avoided. 
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SPECIMEN TRANSPORT 
 Delay in the transport of urine specimen to the laboratory causes the 
contaminating bacteria to multiply readily since urine is an excellent culture 
medium. If there is unavoidable delay of 1-2 hours urine sample can be stored 
in a refrigerator at 4◦C or by addition of 1.8% to the urine sample can prevent 
bacterial mutltiplication. 
 
Processing of urine samples in lab 
MICROSCOPY OF URINE 
WET FILM EXAMINATION [42] 
 It is useful in detecting pus cells, bacteria, red blood cells, casts or 
crystals, yeast and parasites in urine.  
 
GRAM STAINING OF URINE SPECIMEN [42] 
 Finding of one bacterium per oil immersion field correlates with 10 5 
bacteria or more per ml of urine. Absence of bacteria in several fields 
correlates with fewer than 104   bacteria per ml [44] . 
 
CHEMICAL METHODS 
Leucocyte esterase test  
 This test detects enzyme leucocyte esterase present in intact as well as 
lysed leucocytes. In the presence of vaginal fluid, eosinophils and 
Trichomonasvaginalis false positive results are possible.  
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Greiss test  
 Enterobactericeae group of bacteria produce nitrite from nitrate. Greiss 
test detects the presence of nitrite in urine.  The strip is impregnated  with  test  
reagent .  SinceS. saprophyticus, Enterococci, Pseudomonas species do not 
produce nitrite usefulness of this test is limited. The first produced urine 
sample is required  since the bacteria requires more than four hours to convert 
nitrate in to nitrite.  
 
 Simultaneous use of these two tests results in better performance. But 
Griess test and leukocyte esterase have low sensitivity, high specificity, high 
negative predictive values and low positive predictive values [45] 
 
AUTOMATED AND SEMI AUTOMATED SYSTEMS [46] 
 Several semi-automated and automated systems for urine screening 
systems are commercially available. Uncentrifuged urine samples can be 
examined through video camera Sysmex UF -100 and IRIS 939 UDX system. 
These systems are designed to recognize bacteria and leucocytes. A robotic 
instrument cellenium 160- US utilises fluorescent probes to stain bacterial 
monolayer from urine on a membrane and under computerized fluorescent 
microscopy imaging technology it is examined at high magnification. Limited 
clinical data have been published. A variety of automated urinary screen 
systems are in developmental stages and been widely accepted. [45] 
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SIGNIFICANT BACTERIURIA [42] 
 Although the greater part of urinary tract is devoid of commensal flora 
and bladder urine in an uninfected person is free from bacteria, a specimen of 
spontaneous voided urine is apt to be contaminated with some commensal 
bacteria from the urethral orifice and perineum, particularly in females, even 
when the most careful precautions are taken to prevent such 
contamination.The concept of significant bacteriuria was first introduced by 
Kass (1956). He demonstrated that the presence of more than 10 5 cfu/ml in a 
single specimen of urine indicated significant bacteriuria with a probability of 
>80 % and when 2 or 3 consecutive specimens are examined it could be 
increased to >90 % or up to 99% when 2 or 3 consecutive specimens are 
examined .[47]        
 
         Rigid adherence to Kass’s concept should be avoided. Counts between 
10 3 -10 5 are significant in certain clinical situations. Decreased counts are 
obtained when increased fluid intake dilute the urine in symptomatic patients 
or they may have received antimicrobial therapy in the recent past. The 
bacterial count in some patients with uroepithelial damage and recurrent 
infection may not reflect clinical realities [48]. 
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ASYPTOMATIC BACTERIURIA 
 Significant bacteriuria may sometimes occur in the absence of 
symptoms and pyuria in patients who subsequently develops symptoms of 
urinary tract infection, eg. Pregnancy. The detection of such asymptomatic 
bacteriuria is of value, for there is good evidence of its association with the 
development of pyelonephritis in some patients.[49] 
 
FUNGURIA  
 Mostly caused by candida and has become increasingly prominent in 
hospitals. Candida albicans was the single most common microbial species 
isolated. [50] Candiduria is presence of yeast cells in urine. Most patients with 
candiduria are asymptomatic. Colony count of >10 5 /ml of urine is associated 
with infection in patient without indwelling catheters. Clinically significant 
renal candidiasis has been reported even with low colony counts of 10 3 /ml of 
urine. Candiduria most likely reflects colonization or infection of lower 
urinary tractor collecting system of kidneys.[51] 
 
SEMI- QUANTITATIVE CULTURE METHODS [42] 
 Though it is ideal to count the viable bacteriuria in urine by Miles and 
Misra method or pour plate method, they are laborious to use. So standard loop 
method or filter paper method is used. 
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STANDARD LOOP METHOD [42] 
 A Nichrome or Platinum wire of SWG 28 is used. It is made into 
circular loop of 3.26 mm internal diameter. It will hold a drop of water or urine 
of 0.004 ml. When loops holding 0.004 ml or more are used and spread 
uniformly over whole of the plate, colonies are so numerous as to be confluent 
and ther is no single, separate colonies available for picking and the 
preparation of pure subcultures. Loops with fixed volume of 0.001 – 0.01 ml 
are used for semi- quantitative culture. One standard loopful of urine is 
delivered and spread over CLED or over Sheep blood agar plate. Incubate the 
plates aerobically at 35 – 37 ◦ C overnight and number of  colonies grown  
counted and expressed as CFU/ml of urine multiplying count by  1000 if 0.001 
ml of loop is used or 100 if 0.01 ml of loop is used. [42] 
 
FILTER PAPER METHOD [42] 
 Bent a standard 6mm wide absorbent filter paper strip into L shape with 
12 mm long foot. Sterilize the strip by hot air oven at 160◦ C for 1 hour. Whole 
strip is dipped in the urine, drain the excess fluid and place the foot of the strip 
over an  agar plate medium. Remove the strip and incubate the plate at  
35-37oC overnight.  
 
 Colonies growing on the plate are counted. 25 colonies of bacilli or 30 
colonies of cocci corresponds 10 5 CFU/ml approximately.  
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DIP SLIDE METHOD  
           It is a small plastic tray containing a layer of agar culture medium. 
Different media on both sides of the tray. The dip slide is briefly immersed in 
the midstream urine collected in a sterile container, drain the excess urine and 
the disk is replaced in its container. After incubated  at 37 ◦ C overnight and  it 
is examined for growth. The number of colonies grown or pattern of growth 
whether semi-confluent or confluent is compared with charts from the supplier 
to determine the viable count of bacteria [42] 
 
IDENTIFICATION AND SENSITIVITY OF THE TEST 
 Similar colonies found in numbers suggesting significant bacteriuria and 
candiduria are identified by the apppearances of the primary growth on CLED 
or Mac Conkey medium.10 2 CFU ml is also significant in symptomatic 
patients. Colony counts between 10 4 and 10 5 or when multiple species are 
recovered , decision depends on clinical information of the patient. Antibiotic 
sensitivity depend upon the isolate and clinical condition of the patient [42]. As 
antibiotics are concentrated in urine to higher levels than are found in the 
tissues, high content discs should be used. [49] 
  
 
 
 
 
Materials and methods 
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MATERIALS AND METHODS 
 
Study period 
        This cross sectional study was carried out in the Institute of 
Microbiology, Madras Medical College in association with Department of 
Urology, Rajiv Gandhi Government General Hospital, Chennai over a period 
of one year. This study was reviewed and approved by Institutional ethical 
committee, Madras Medical College.           
 
       Patient’s undergoing Urodynamic procedure and Cystoscopy were taken 
under the study. Informed consent was obtained from the study population. All 
patients satisfying the inclusion criteria were documented. Patients were 
interviewed by structured questionnaire. All data were handled anonymously 
and confidentially. 
 
SAMPLE COLLECTION 
They were requested to give three samples of midstream urine ‘clean 
catch’ to the microbiological laboratory in a wide mouthed universal container 
with a secured lid.  A proper instruction was given to the patient regarding the 
collection of midstream urine sample. 
 
 Male patients were asked to retract the prepuce, cleanse the glans penis, 
with soap and water and then collect the sample from the middle urine flow. 
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Female patients were instructed thoroughly to clean the ano-genital area from 
front to back, pass urine with labia separated and collect sample from middle 
portion of stream.  
 
           Three samples of urine were collected from the patients. First urine 
sample was collected just before the procedure, second urine sample was 
collected at the third day and third urine sample was collected at the 7th day 
after the procedure. 
 
SAMPLE SIZE 
PROCEDURE NUMBER OF PATIENTS 
NUMBER OF 
SAMPLES 
Cystoscopy 100 3X100=300 
Urodynamic study 100 3X100=300 
TOTAL 200 600 
   
Inclusion criteria 
1. Patients who were selected for cystoscopy and urodynamic study. 
2. Patients who were above 18 years of age. 
3. Samples which were found to be negative for urine culture prior to the 
procedure and on the day of the procedure. 
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Exclusion criteria: 
1. Samples which were found to be positive for urine culture prior to the 
procedure and on the day of the procedure. 
2. Patients on antibiotics. 
 
STUDY: 
SAMPLE PROCESSING 
 Under strict aseptic precautions samples were collected from the 
patients and since urine is an excellent culture medium supporting rapid 
growth of many bacteria it was transported immediately to the laboratory in 
appropriate settings and sample processing was done within one hour. 
 
WET FILM EXAMINATON [42] 
 Urine sample was mixed carefully and about 0.05 ml of urine was 
placed in the middle of the microscopic slide. At once a NO.1 cover slip of 
22x22 mm in dimensions was placed over it, taking care to avoid air bubbles. 
The preparation was placed under high power objective [40x] of light 
microscope. The number of pus cells per high power field was recorded. 
Observation was also done for the presence of epithelial cells, red blood cells, 
parasites, yeasts (budding yeast cells and pseudohyphae) and bacteria. All 
these findings were recorded. 
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GRAM STAINING [42] 
 A drop of well mixed uncentrifuged urine was air dried over a 
microscopic slide, heat fixed and Gram’s staining was carried out. The stained 
smear was examined under oil immersion [100x] for bacteria and yeast cells 
and their number per field was recorded. 
 
TABLE-3    BACTERIAL COUNT BY DIRECT EXAMINATION OF 
URINE [44] 
SAMPLE UNSTAINED CFU/ml [wet mount] 
STAINED CFU/ml 
[Gram stain] 
UNCENTRIFUGED ≥ 106 ≥ 105 
CENTRIFUGED ≥ 105 ≥ 104 
 
 CFU/ml –extrapolated from the finding of one bacterium per 
microscopic field. 
 
 CFU/ml-colony forming units. 
 
SEMI QUANTITATIVE CULTURE [42] 
            A calibrated loop that delivers 0.001 ml of urine was used to culture 
urine sample semi-quantitatively. A loopful of urine was surface plated on 
CLED agar. Urine sample was mixed thoroughly, the calibrated loop was 
inserted vertically in to the urine sample and the sample was inoculated on 
CLED media and streaked to obtain individual colonies.  
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Streaking technique[52] 
 Nonferrous (Nichrome or platinum) or disposable plastic inoculating 
loops, calibrated to contain 0.001 ml of fluid, was immersed into an 
uncentrifuged urine sample. The loop was then carefully removed and the 
entire volume was delivered to the surface of an agar plate by making a single 
streak across the center. The inoculum was spread evenly at right angles to the 
primary streak: then the plate was turned 90 degrees and the inoculum was 
spread to cover the entire surface. 
 
 The plated cultures were incubated at 37° C for 24 hours. The number of 
colonies grown on the surface of the agar were counted after 18 to 24 hours of 
incubation and interpreted as CFU/ml of urine by multiplying the number of 
colonies grown by 1000. The colony counts exceeding 105 CFU/ml was taken 
as significant colony count. 
 
IDENTIFICATION AND SENSITIVITY TEST 
 Colonies suggesting  bacteriuria / candiduria were processed. 
Phenotypic identification of uropathogens was carried out by means of 
biochemical reactions. Selection of battery of test depended on organism.    
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ISOLATION, IDENTIFICATION AND SPECIATION OF BACTERIAL 
ISOLATES 
 Growth in CLED medium was identified. Lactose fermenting [LF] 
colonies were identified based on motility, catalase test, nitrate reduction, 
methyl red test, VogesProskauer, production of indole, H2S, urease, citrate 
utilization  and sugar fermentation tests. Non lactose fermenting [NLF] 
colonies were grouped under Enterobactericeae based on oxidase production, 
catalase production, reduction of nitrate to nitrite.  
 
 Further speciation depended on motility, fermentative/oxidative 
metabolism of sugars, phenyl alanine deaminase test and battery of sugars, 
production of indole, H2S, urease, citrate utilization   and decarboxylation of 
lysine, arginine and ornithine in Moeller’s decarboxylation media. 
 
 Gram positive cocci morphologically resembling Staphylococci were 
identified by coagulase test and novobiocin sensitivity. Suspected enterococci 
colonies were identified by bile esculin agar, growth in the presence of 6.5 % 
sodium chloride and fermentation of sugars in peptone water sugar media. 
 
DETECTION OF MOTILITY [42] 
 Motility was done by hanging drop method for actively motile bacteria.              
Detection of motility is important in identifying the bacilli. 
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Antimicrobial sensitivity tests[42] 
 Antimicrobial sensitivity tests was carried out by Kirby Bauer disc 
diffusion method on Mueller Hinton agar [Hi Media, Mumbai, India].The 
media was prepared by suspending 38 grams of dehydrated media in 1000 ml 
distilled water, autoclaved at 121 ◦ C for 15 minutes and poured in to petri 
dishes to a depth of 4 mm. A broth culture of the isolate with turbidity 
equivalent to Mc Farland 0.5 turbidity standard was lawn cultured over the 
Mueller Hinton agar and allowed to dry.  
 
        The antibiotic discs contained in the catridges were taken out from the 
refrigerator half hour earlier and brought to room temperature. Antibiotic discs 
were applied to MH agar surface seeded with test bacterium and incubated at 
37 ◦ C. The antibiotic discs used were from Hi Media and the following 
antibiotic discs were used amikacin, ampicillin, Penicillin, Amoxyclave, 
Cephalexin, Ceftazidime, Cefotaxime, Ciprofloxacin , Gentamicin, 
nitrofurantoin, norfloxacin ,Erythromycin, Cefoxitin, High level gentamycin 
and Tetracycline. 
 
 The antibiotic susceptibility test was interpreted as sensitive or resistant 
by comparing the inhibitory zone size produced by test organism with that of 
standard strains of bacteria. The standard strains used were Staphylococcus 
aureus ATCC 25923 ,Escherichia coli ATCC 25922 and Pseudomonas 
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aeruginosa ATCC 27853.The selection of battery of antibiotic discs was based 
on organisms isolated from UTI. 
 
ISOLATION, IDENTIFICATION AND SPECIATION OF COMMON 
FUNGAL ISOLATES 
 Colonies resembling candida were identified by growth at 37 ◦ C, 
Gram’s stain and germ tube test. Further speciation of candida by cornmeal 
agar, Chrom agar, sugar fermentation and assimilation tests. 
 
Gram stain 
 From an isolated colony a smear was made and stained by Gram’s stain 
and examined under oil immersion for the presence of gram positive budding 
yeast cells and pseudohyphae. 
 
Germ tube test 
 An isolated colony of yeast was added to 0.5 ml of human serum in a 
sterile test tube and incubated at 37◦C for two hours. A drop of this suspension 
is placed on a slide with cover slip applied over it and observed for presence of 
germ tube under high power microscope. 
 
 Positive  - Candida albicans / Candida dubliniensis 
 Negative  - Candida non albicanspp 
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CORN MEAL AGAR [Dalmau plate culture technique] 
 Using a straight wire an isolated colony from primary culture was 
inoculated by making three parallel lines half an inch apart into corn meal agar 
plate and covering the portion of the streaks with sterile coverslip. Examined 
under low power and then under high power objective after 48 hours of 
incubation at 25◦C where cuts are made for the presence of hyphae, 
blastoconidia, arthroconidia and chlamydospores. 
 
TABLE-5 MORPHOLOGY ON CORN MEAL AGAR 
Candida albicans Terminal chlamydospores. 
Candida tropicalis 
Abundant pseudohyphae, pine forest 
arrangement, blastoconidia formed at or in 
between septa. 
Candida krusei Elongated yeasts, abundant pseudohyphae(match stick like appearance) 
Candida guilliermondi Giant hyphae, blastospores at nodes. 
Candida glabrata Only yeasts. 
Candida lusitaniae Short, distinctly curved pseudohyphae with occasional blastoconidia at septa. 
Candida parapsilosis Fine pseudomycelium with single or small clusters of blastoconidia and giant cells. 
Candida kefyr 
Abundant pseudomycelium of elongate cells 
that lie parallel giving log in stream appearance. 
Infrequent blastoconidia. 
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CANDIDA CHROM AGAR   
 A single yeast colony from sub culture of Sabourauds Dextrose agar was 
streaked on to plates. After incubation of 48 hours at 37◦C the colour and the 
colony morphology was noted. 
 
TABLE-6    APPEARANCE ON CHROM AGAR 
SPECIES COLOUR MORPHOLOGY 
Candida albicans Green - 
Candida tropicalis Steel blue - 
Candida krusei Pink pale borders Medium to large flat, rough. 
Candida guilliermondi Pink to lavender - 
Candida glabarata Dark violet Small to medium, smooth convex creamy. 
Candida lusitaniae Pink to lavendar Waxy, large rough 
Candida parapsilosis Ivory to pink to lavender Small to medium, smooth wrinkled. 
Candida kefyr Pink to lavender Large, rough 
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SUGAR FERMENTATION TESTS 
 0.2 ml suspension of 24-48 hours culture from sugar free media was 
added to 2% sugar fermentation media with Andrade indicator and incubated 
at 30 ◦ C for 48 to 72 hours. Acid and gas production indicates fermentation. 
Glucose, maltose, sucrose, lactose sugars were tested. 
 
TABLE-7 FERMENTATION REACTION 
SPECIES GLUCOSE MALTOSE SUCROSE LACTOSE 
C. albicans F F - - 
C. tropicalis F F F/V - 
C. krusei F - - - 
C.guilliermondi F - - - 
C. glabrata F - - - 
C. lusitaniae F F - - 
C. parapsilosis F - - - 
C. kefyr F - F F 
F- acid and gas, V- variable 
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SUGAR ASSIMILATION TEST 
 To the yeast suspension from 24- 48 hours culture grown in sugar free 
media 2 ml of yeast nitrogen base was added. To this 18 ml of molten agar 
added, cooled to 45◦ C, poured into sterile petri plate and allowed to set. 
Carbohydrate discs [Hi Media] dextrose, sucrose, lactose, trehalose and 
cellibiose were placed on the agar and incubated at 30 ◦ C for 24-48 hours. 
Growth around the discs indicates assimilation. 
 
TABLE-8 CARBOHYDRATE ASSIMILATION 
SPECIES GLUCOSE TREHALOSE SUCROSE LACTOSE CELLEBIOSE
C. albicans + + v - - 
C. tropicalis + + V - + 
C. krusei + - - - - 
C.guilliermondi + + + - + 
C. glabrata + + - - - 
C. lusitaniae + + + - + 
C. parapsilosis + + + - - 
C. kefyr + - + + + 
 
+ positive, - negative, V variable 
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ANTIMICROBIAL SENSITIVITY TESTING 
ANTIBACTERIAL SUSCEPTIBILITY 
Disc diffusion method : 
 Antibiotic sensitivity was assessed by Kirby –Bauer disc diffusion 
method using the Mueller-Hinton agar plate for all the isolates.  
 
 The isolate was sub cultured on sheep blood agar, to obtain a pure 
culture. To get the organism in the logarithmic phase three to four colonies 
were suspended in nutrient broth and were incubated for two hours at 37ºC. 
The density of the suspension was standardized to 0.5 McFarland units. Within 
fifteen minutes of preparation of the suspension, a sterile cotton-wool swab 
was dipped into the suspension and the surplus was removed by rotating the 
swab against the side of the test tube.  
 
 To obtain a lawn culture the agar plate was inoculated by even stroking 
of the swab over the entire surface of the plate in three directions. The 
antibiotic discs were placed, six on each plate after drying. With each batch of 
tests, a control for each antibiotic was also set up. As per the CLSI guidelines 
the control strains were included and obtained from American Type Culture 
Collection (ATCC). 
 
 Following panel of drugs were used for antimicrobial sensitivity testing  
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TABLE-9 Drugs used for antimicrobial sensitivity testing 
ANIBIOTICS DISC CONTENT
RESISTANT
(mm) 
INTER- 
MEDIATE 
(mm) 
SENSITIVE 
(mm) 
Cefotaxime 
Enterobactericeae, 
Acinetobacterspp 
30µg ≤22 ≤14 
23-25 
15-22 
≥26 
≥23 
Ceftazidime 
Enterobactericeae, 
Acinetobacterspp 
30µg ≤14 ≤18 
18-20 
15-17 
≥ 21 
≥18 
Amikacin 
Enterobactericeae 
S.aureus, 
Pseudomonasaeruginosa, 
Acinetobacterspp 
30µg ≤ 14 15-16 ≥ 17 
Gentamycin 
Enterobactericeae, 
Pseudomonas 
aeruginosa, 
Acinetobacterspp 
10µg ≤ 12 13-14 ≥ 15 
Ciprofloxacin 
Enterobactericeae, 
S.aureus, Pseudomonas 
aeruginosa, 
Acinetobacterspp 
5µg ≤ 15 16-20 ≥ 21 
Ampicillin 
Enterobactericeae 
Enterococcus spp 
10µg ≤13 ≤8 
14-16 
- 
≥17 
≥17 
Nitrofurantoin 
Enterobactericeae, S. 
aureus, Enterococcus spp 
300µg ≤14 15-16 ≥17 
Norfloxacin 
Enterobactericeae, 
S.aureus, Enterococcus 
spp, Pseudomonas 
aeruginosa 
10µg ≤12 13-16 ≥17 
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ANIBIOTICS DISC CONTENT
RESISTANT
(mm) 
INTER- 
MEDIATE 
(mm) 
SENSITIVE 
(mm) 
Cefoxitin 
S.aureus, 30µg ≤21 - ≥22 
Amoxyclav 
Enterobactericeae 20/10µg ≤ 13 14-17 ≥ 18 
Tetracycline 
Enterobactericeae 
S.aureus 
30µg ≤ 11 ≤14 
12-14 
15-18 
≥ 14 
≥19 
Penicillin 
S.aureus 
Enterococcus spp 
10units ≤28 ≤14 
- 
- 
≥29 
≥14 
High level gentamicin 
Enterococccusspp 120µg 6 7-9 ≥10 
Trimethoprim- 
sulfamethoxazole 
S.aureus, 
acinetobacterspp 
1.25/23.75µ
g ≤10 11-15 ≥16 
Erythromycin 
S.aureus, Enterococcus 
spp 
15µg ≤13 14-22 ≥23 
 
ESBL Detection by Disc Potentiation Test: 
Jariler et al. first described this method in 1988 for Enterobacteriaceae. 
In this method a lawn culture of test isolate was made as per CLSI 
guidelines.[48]Ceftazidimeclavulanic acid disc and ceftazidime disc was  placed  
at a distance of 30mm from centre to centre. The test isolate was considered to 
produce ESBL, if the zone size around the β lactamase inhibitor combination 
disc was increased by ≥5mm. ATCC Escherichia coli 35218 was used as 
control. 
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Minimum inhibitory concentration (MIC) for Vancomycin by macrobroth 
dilution method 
1. Culture media:  
Cation adjusted Mueller Hinton broth (pH 7.2-7.4) 
 
ANTIBIOTIC STOCK SOLUTION 
 Antibiotic stock solution can be prepared using the formula 
  1000 
W  =--------------------- x V x C 
  P 
 
 Where P= potency of the antibiotic in relation to the base. (For 
Vancomycin 
P= 950/1000 µg) 
 
                  V = volume of the stock solution to be prepared (10ml) 
                  C = final concentration of the antibiotic solution (1024μg/ml) 
                 W = weight of the antibiotic to be dissolved in the volume V 
 
PEAPARATION OF DRUG DILUTIONS 
 Two rows of sterile test tubes were arranged one for the test and the 
other for the ATCC control with 1 ml of MH broth. From the stock solution 
(tube 1) 1ml was transferred to the second tube, then from the second to the 
third tube. This procedure was repeated till the thirteenth tube. Growth control 
and the sterility control for the antibiotic solution was also kept. 
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Inoculum preparation for the test and ATCC control and incubation 
 To 9.9 ml of MH broth 0.1ml of 0.5 Mcfarland turbidity matched test 
isolate suspension was added, mixed well and from this 1 ml of inoculum was 
transferred to each tube containing antibiotic dilutions and also to the control 
tube. Same procedure was repeated for ATCC control strain and incubated at 
37ºC – overnight. MIC of ATCC control strain and the test organism was 
observed. The lowest concentration of the antibiotic in which there is no 
visible growth is considered as the MIC for the ATCC strain & for the test 
organisms.  
 
TABLE -10 SERIAL DRUG DIUTION AND DRUG CONCENTRATION 
Tubes 1 [Stock] 2 3 4 5 6 7 8 9 10 11 12 13 
Amount( ml) of MH 
broth to be added 2 1 1 1 1 1 1 1 1 1 1 1 1 
Serial dilution of 
drug-1 ml to be 
transferred 
 
Fr
om
 1
 
Fr
om
 2
 
Fr
om
 3
 
Fr
om
4 
Fr
om
 5
 
Fr
om
6 
Fr
om
 7
 
Fr
om
8 
Fr
om
9 
Fr
om
 1
0 
Fr
om
 1
1 
Fr
om
 1
2 
Drug 
concentration(µg/ml) 1024 512 256 128 64 32 16 8 4 2 1 0.5 0.25 
Addition of 
inoculum (1 ml)  1 1 1 1 1 1 1 1 1 1 1 1 
concentration  256 128 64 32 16 8 4 2 1 0.5 0.25 0.125
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 Interpretation: 
 Only if the MIC of the ATCC strain is in the sensitivity range the MIC 
for the test isolate is read otherwise test is invalid. The MIC for the drug and 
the test isolate is the lowest concentration of the antibiotic in which there is no 
visible growth. 
 
TABLE-11-A MIC range for Vancomycin by macrobroth dilution method 
VANCOMYCIN RESISTANT µg/ml 
INTERMEDIATE 
µg/ml 
SENSITIVE 
µg/ml 
S.aureus ≥32 8-16 ≤4 
Enterococci.spp ≥16 4-8 ≤2 
 
ANTIFUNGAL SUSCEPTIBILITY 
DISC DIFFUSION METHOD 
 Isolates to be tested were subcultured on SDA to obtain pure and viable 
cultures. Inoculum was prepared by suspending 4-5 colonies of 24 hour old 
culture in 5 ml sterile NaCl (0.85%) and adjusted to 0.5 McFarland’s turbidity 
standard.  
 
 Within fifteen minutes of preparation of the suspension, a sterile cotton-
wool swab was dipped into the suspension and the surplus was removed by 
rotating the swab against the side of the test tube.      
 
46 
 
 With this swab, the Mueller Hinton agar supplemented with 2% glucose 
and 0.5 µg/ml methylene blue plate was inoculated by even stroking of the 
swab over the entire surface of the plate in three directions so as to obtain a 
lawn culture.     
 
 After brief drying, the antibiotic disc was placed on each plate. With 
each batch of tests, a control for each antibiotic was also set up.  
 
 The control strains were obtained from American Type Culture 
Collection (ATCC). The control strains were included as per the CLSI 
guidelines. Antifungal discs used were Fluconazole [25µg] and voriconazole 
[1µg]. 
 
TABLE-12 Antifungal susceptibility and their interpretative criteria 
ANTIFUNGAL DISC POTENCY 
ZONE DIAMETR RANGE 
R SDD S 
FLUCONAZOLE 25µg ≤14 15-18 ≥19 
VORICONAZOLE 1µg ≤13 14-16 ≥17 
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DETERMINATION OF MINIMUM INHIBITORY CONCENTRATION 
[MIC] BY MICRO BROTH DILUTION METHOD 
 As per M27-A3 document in CLSI guidelines MIC for yeast is detected. 
MEDIA- RPMI [Rose Well Park Memorial Institute] 1640 medium with L-
glutamine, without sodium bicarbonate buffered with MOPS[3-(N-
morpholino) propane sulfonic acid].To dissolve water insoluble drugs 
DMSO[dimethyl sulfoxide] is used. 
 
INOCULUM PREPARATION 
 Isolates to be tested were subcultured on SDA to obtain pure and viable 
cultures. Inoculum was prepared by suspending 4-5 colonies of 24 hour old 
culture in 5 ml sterile NaCl [0.85 %], vortexed , adjusted to 0.5 McFarland’s 
turbidity standard at 530 nm wavelength in a spectrophotometer and further 
diluted 1:50 with the standard medium so that the test inoculum is 1x 103 to  5 
x 103 CFU/ml. 
 
Weight of antifungal drugs 
Weight (mg) = volume(ml) x concentration ( µg/ml) 
Assay potency (µg/mg) 
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PREPARATION OF STOCK SOLUTION 
 Water soluble drug fluconazole dissolved in distilled water in the 
concentration of 5120 µg/ml. Water insoluble drugs like itraconazole, 
ketoconazole and voriconazole dissolved in DMSO in the concentration of 
1600 µg/ml. 
 
INTERMEDIATE DRUG CONCENTRATION 
WATER INSOLUBLE DRUGS 
 Ten tubes arranged in a row. Stock solution 1600 µg was taken in first 
tube. 0.5 ml of DMSO in the second, fifth and eighth tubes, 1.5 ml of DMSO 
in the third, sixth and nineth tubes and 3.5 ml of DMSO in fourth, seven and 
tenth tubes were added.  
 
 From the first tube 0.5 ml of the drug was transferred to second, third 
and fourth tubes. From the fourth tube 0.5ml was transferred to fifth, sixth and 
seventh tubes. From the seventh tube 0.5 ml was transferred to eight, nineth 
and tenth tubes. 
 
WATER SOLUBLE DRUGS 
 Ten tubes were arranged in a row. 7 ml of RPMI was added to the first 
tube. 1ml of RPMI was added to second, fourth, seventh and tenth tubes. 3 ml 
of RPMI was added to third tube. 1.5 ml of RPMI was added to fifth and 
eighth tubes. 3.5 ml of RPMI was added to the sixth and nineth tubes.  
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 1ml of drug was added to the first tube [stock].From the first tube 1 ml 
was transferred to second, third and fourth tubes. From the fourth tube 0.5 ml 
was transferred to fifth and sixth tubes. From the sixth tube 1 ml was 
transferred to seventh tube and 0.5 ml to the eighth and nineth tube. From the 
nineth tube 1ml was transferred to tenth tube. 
 
FINAL DRUG CONCENTRATION 
WATER INSOLUBLE DRUG 
 Another row of ten tubes are arranged and 4.9 ml of RPMI added in all 
the tubes. To these 0.1ml of intermediate drug prepared were added from the 
corresponding rows. 
 
WATER SOLUBLE DRUG 
 Another row of ten tubes are arranged and 4 ml of RPMI added in all the 
tubes. To these 1ml of intermediate drug prepared were added from the 
corresponding rows. 
 
 METHOD100µl of each serial dilution of antifungal agents and a 
constant volume100µl of inoculum were added in the wells of flat bottomed 96 
well microtitre plate. Incubated at 35º C for 48 hours. Growth and drug control 
were included. 
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TABLE-13 Antifungal drug concentrations for water insoluble drugs 
TUBES 
(water 
insoluble) 
1 2 3 4 5 6 7 8 9 10 
In
te
rm
ed
ia
te
 
dr
ug
 
co
nc
en
tr
at
io
n 
1600 800 400 200 100 50 25 12.5 6.25 3.13 
Fi
na
l d
ru
g 
co
nc
en
tr
at
io
n 
32 16 8 4 2 1 0.5 0.25 0.125 0.0625 
dr
ug
 
co
nc
en
tr
at
io
n 
af
te
r 
ad
di
ng
 
in
oc
ul
um
 
16 8 4 2 1 0.5 0.25 0.125 0.0625 0.0313 
 
TABLE-14 Antifungal drug concentrations for water insoluble drugs 
TUBES 
(water 
soluble) 
1 2 3 4 5 6 7 8 9 10 
Intermediate 
drug 
concentration 
640 320 160 80 40 20 10 5 2.5 1.25 
Final drug 
concentration 128 64 32 16 8 4 2 1 0.5 0.25 
drug 
concentration 
after adding 
inoculum 
64 32 16 8 4 2 1 0.5 0.25 0.125 
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 Growth control was added to column 11, with 100μl of RPMI and 100μl 
of inoculum. Drug control was added to column 12 with 100μl of RPMI and 
100μl of drug.  
 
 INCUBATION 
 The microtitre plate was incubated at 35°C for 24 hours for Candida 
species. 
 
Reading of results and scores:  
1- Optically clear absence of growth 
2- Approximately 25% of the growth control or Slight growth. 
3- Approximately 50% of the growth control or prominent reduction in 
growth. 
4- Approximately as of the growth medium or slight reduction in the 
growth. 
5- No reduction in the growth. 
 
INTERPRETATION 
 The MIC for azole drugs was the lowest concentration with a score of 3. 
This corresponds to approximately 50% of the growth control or prominent 
reduction in growth. 
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TABLE-11-B MIC range for Azole drugs by  
macrobroth dilution method 
 
Candida .spp RESISTANT µg/ml 
SUSCEPTIBLE 
DOSE RANGE      
µg/ml 
SENSITIVE 
µg/ml 
Fluconazole ≥64 16-32 ≤8 
Itraconazole ≥1 0.25-0.5 0.125 
Voriconazole ≥4 2 ≤1 
 
MOLECULAR METHOD:    
Polymerase chain reaction: 
 The isolates of E.coli which were having > 10 5 CFU/ml by 
semiquantitative culture method were subjected to conventional PCR for the 
detection of ompT gene.[] 
 
DNA extraction:  
 5-10 colonies ofE.coliwere inoculated into nutrient broth andincubated 
overnight at 37ºC. 1.5ml of overnight broth culture was transferredinto 1.5ml 
of centrifuge tube and centrifuged at 10,000 rpm for 3 minutes. Supernatant 
was discarded, excess medium was removed by gently tappingthe tube on a 
paper towel. 
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Procedure: 
1. The pellet obtained was suspended in 200µl of PBS. 
2. 180µl of Lysozyme digestion buffer and 20µl of Lysozyme were added. 
3. Above mixture was mixed well and incubated at 37 ºC for 15min. 
4. After incubation 200µl of Lysis buffer and 20µl of Proteinase K 
[10mg/ml] were added and incubated at 56ºC for 10min in waterbath. 
5. Then 300µl of Isopropanol was added and mixed well. 
6. The whole lysate was transferred into PureFast spin column and 
centrifuged at 10000rpm for 1min. 
7. Flow through was discarded and 500µl of Wash buffer-1 was added to 
spin column and centrifuged at 10000rpm for 1min. 
8. Flow through was discarded and 500µl of Wash buffer-2 was added to 
spin column and centrifuged at 10000rpm for 1min. washing was 
repeated one more time. 
9. Flow through was discarded and the column was centrifuged for 
additional 2 minutes to remove any residual ethanol. 
10. The DNA was eluted by adding 100µl of Elution buffer and centrifuged 
for 1min. The eluted DNA was used as the template for PCR. 
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Primers: [Designed by HELINI Biomolecules, Chennai] 
GENE PRIMER SEQUENCES 
AMPLICON 
SIZE IN BASE 
PAIRS 
ompT 5'-CACGCTCCACAAACCAAGTG-3 1120 
 
PCRProcedure: 
1. Reactions were set up as follows; 
Components Quantity 
HELINI 2X PCR Master Mix 10μl 
Primer Mix 10pmoles/Reactions 5μl 
Genomic DNA 5μl 
Total volume 20μl 
 
2. All the components were mixed gently and placed into PCR machine 
(Corbett thermocycler) and programmed it as follows, 
 
Cycle Number Denaturation Annealing Extension 
1 94ºC for 5 min - - 
35 94ºC for 30sec 58ºC for 30sec 72ºC for 30sec 
1 - - 72º C for 5 min
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Agarose gel electrophoresis: 
1. 2% agarose gel was prepared [2gm of agarose in 100ml of 1x TAE 
buffer] with eight wells. 
2.  8μl 6X Gel loading dye was mixed to each PCR vial. 
3. 15μl from each PCR vial was loaded. 
4. Then 100bp and 1000 bp DNA ladder and appropriate controls were 
loaded. 
5. Electrophoresis was run at 50V till for 40 min and the bands were 
observed using UV Transilluminator. 
 
Interpretation: 
 The amplified PCR products and 100bp 1000 bp DNA molecular 
markerswere seen as bright fluorescent bands with satisfactory controls. A 
1120bp corresponds to ompT gene. 
 
  
 
 
 
 
Results 
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RESULTS 
 
 A total of 600 midstream urine samples were processed from 100 
patients each undergoing cystoscopy and urodynamic procedure attending 
urology OP, Rajiv Gandhi Government General Hospital, Chennai.  
 
 From each patient 3 urine samples were collected on the day 0 (just 
before the procedure), day 3 (3 days after the procedure) and day 7 (7 days 
after the procedure). So 300 samples were collected from 100 patients each 
undergoing cystoscopy and urodynamic procedure accounting to 600 samples. 
 
 Samples collected just before the procedure (day 0) which were culture 
positive were subsequently excluded from the study. Patient selection criteria 
will be based on only when the midstream urine samples is declared negative 
for urinary tract infection. 
 
 The results will be discussed separately for the two groupsi.e cystoscopy 
and urodynamic procedure. 
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CYSTOSCOPY 
TABLE-15 Age and Sex wise distribution of samples collected from 
cystoscopy patients 
 
 Among the100 patients underwent cystoscopy 55(55%) of them were 
male patients and 45 (45%)of them were female patients. Majority of the 
patients were from the 51-60 (36%) age group followed by the 41-50 (24%) 
age group in the both genders. Least number of patients were from <30 (5%) 
age group and the 71-80 (9%) age group in the both genders. 
Age Male Female Total 
21-30 4 (7.27%) 1 (2.22%) 5(5%) 
31-40 8 (14.5%) 3 (6.66%) 11 (11%) 
41-50 13 (23.6%) 11 (24.4%) 24 (24%) 
51-60 16 (29%) 20 (44.4%) 36 (36%) 
61-70 7 (12.7%) 8 (17.7%) 15 (15%) 
71-80 7 (12.7%) 2 (4.44%) 9 (9%) 
Total 55 (55%) 45 (45%) 100 
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TABLE-16 Age and Sex wise distribution of culture positive patients 
Age 
Male Female Total Total 
Culture 
+ve 
patients 
(%) 
No. of 
patients 
No. of 
Culture 
+ves 
No. of 
patients
No. of 
Culture 
+ves 
No. of 
patients 
Culture 
+ve 
patients
21-30 4 1 (25%) 1 1(100%) 5 2 40 
31-40 8 2 (25%) 3 1(33.33%) 11 3 27.27 
41-50 13 6 (46%) 11 5(45.55%) 24 11 45.83 
51-60 16 6 (37.5%) 20 7(25.9%) 36 13 36.11 
61-70 7 3 (42.8%) 8 2(25%) 15 5 33.33 
71-90 7 3 (42.8%) 2 1(50%) 9 4 44.44 
Total 55 21(38.18%) 45 17(37.77%) 100 38 38 
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 Above table shows that 38 patients (38%) were culture positive among 
100 patients underwent cystoscopy. Among these 38 culture positives 21 
(38.18%) were males and 17 (37.77%) were females. Majority of the culture 
positive patients were between 41-50 (45.83%) age group in the both genders. 
 
 
 
Table- 17   Correlation between pyuria, Gram’s stain and culture 
Gram’s 
stain 
showing 
bacteria 
Growth 
on 
culture 
Wet mount 
No. of pus cells/HPF 
[High power field] 
Total 
samples 
-300 
Total 
% 
0-3/HPF 3-5/HPF >5/HPF 
Absent 
Absent 243 15 2 260 86.66 
Present - 2 29 31 10.33 
Present Present - 2 7 9 3 
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Total
Age and Sex wise distribution of culture positive 
patients 
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 Above table shows that among 300 samples only 9(3%) samples showed 
bacteria on Gram stain and the remaining 291 samples does not show any 
bacteria on Gram stain. Among the 291 samples 260(86.66%) samples were 
culture negative and 31 (10.33%) samples were culture positive. Among the 
260 samples 243 samples had 0-3 pus cells, 15 samples had 3-5 pus cells and 2 
samples had >5 pus cells per high power field. Among the 31 samples 2 
sample had 3-5 pus cells and 29 samples had > 5pus cells per high power field. 
All the 9 samples showing bacteria on Gram stain were culture positive. 
Among these 2 samples had 3-5 pus cells and 7 samples had > 5 pus cell per 
high power field.   
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Table-18 Distribution of Culture +ve and Culture –ve patients 
Gender No.of pts 
Culture +ve Pts 
Culture -ve Pts No.of Pts with 
Single 
isolate 
No.of Pts 
with Mixed  
isolates(2 
isolates) 
Total 
No.ofCult
ure+ve 
Pts 
Male 55 19 2 21 34 
Female 45 14 3 17 28 
Total 100 33(33%) 5(5%) 38(38%) 62(62%) 
 
 Among the total 100 patients 38(38%) patients were culture positive 
and 62 (62%) patients were culture negative. Among the 38 culture patients 33 
(33%) were culturepositive for single organism on culture and 5 (5%) were 
culture positive for mixed organisms. 
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Table-19 Daywise analysis for Culture +ve single organism 
 No. of pts 
Culture +ve for single organism 
3rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
Male 19 15 3 1 
Female 14 9 4 1 
Total 33 24(24%) 7(7%) 2(2%) 
 
 Among the 33 culture positive patients for single isolates 19 patients 
were from males and 14 patients were from females. Majority of the patients 
yielded growth on the third day. 24 patients yielded growth on third day and 
these patient were culture negative on seventh day, 7 patients who yielded  no 
growth on third day were yielded growth on seventh day and only 2(2%) 
patients yielded growth on both third and seventh day. 
 
Table-20 Daywise analysis for Culture +ve for mixed organism 
 No. of pts 
Culture +ve for mixed organism(2 isolates) 
3rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
Male 2 2 - 0 
Female 3 2 1 0 
Total 5(5%) 4(4%) 1(1%) 0 
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 Among the 5(5%) culture positive patients for mixed isolates 2 
patients were from males and 3 patients were from females. Majority of the 
patients yielded growth on the third day. 4(4%) patients yielded growth on 
third day, 1 (1%)patient yielded growth on seventh day. None of patients 
yielded mixed growth on both third and seventh day. 
 
Table- 21 Day wise distribution of single isolates 
Isolates Total 3
rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
E.coli 12 8 2 2 
Klebsiella.spp 5 4 1 - 
Proteus .spp 6 5 1 - 
Acinetobacter.spp 3 2 1 - 
Enterococci 2 1 1 - 
Pseudomanasaeruginosa 2 2 - - 
Candida. Spp 2 1 1 - 
Staph.aureus 1 1 - - 
Total 33 24 7 2 
 
 Majority of them were isolated on third day i.e 24 out of 33 (72.7%), 7 
were isolated on seventh day (21.2%) and 2 were (6%) isolated on both third 
and seventh day. 
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Table-22 Day wise distribution of mixed isolates 
No of Culture +ve patients for mixed organism(2 isolates) 
Mixed Isolates 3
rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
E.coli+Enterococci 
E.coli+Klebsiellaspp 
1 
1 - 0 
E.coli+ Enterococci 
E.coli+CONS 
1 
1 
 
- 0 
E.coli+C.albicans - 1 0 
Total 4(80%) 1(20%) 0 
 
 Out of five patients four (80%) patients yielded two isolates on third 
day, 1 (20%) patient yielded two isolates on seventh day and none of the 
patients yielded mixed isolates on both third and seventh day. 
 
Table- 23 Day wise distribution of single and mixed isolates 
Isolates Total 3
rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
E.coli 17 13 2 2 
Klebsiella.spp 6 5 1 - 
Proteus .spp 6 5 1 - 
Acinetobacter.spp 3 2 1 - 
Enterococci 4 2 2 - 
CONS 1 1 - - 
Pseudomanasaeruginosa 2 2 - - 
Candida. Spp 3 2 1 - 
Staph.aureus 1 1 - - 
Total 43 33 8 2 
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 The table above shows that among the total 43 isolates 33(76.67%) were 
isolated on the third day, 8(18.6%)were isolated on the seventh day and 2 
(4.6%) were isolated on both third and seventh day.  
 
 Majority of the isolates were E.coli (39.5%) followed by Klebsiella .spp 
(13.33 %), Proteus .spp (13.33 %), Enterococci (8.89%), Acinetobacter.spp( 
6.67%), Candida. Spp( 6.67%), Pseudomonas aeruginosa (4.44%), 
Staphylococcus aureus (2.22%) and CONS (2.22 %). 
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Table -24 Distribution of isolates among different age groups 
Isolates 
Age group 
To
ta
l 
is
ol
at
es
 
21-30 31-40 41-50 51-60 61-70 71-90 
E.coli 2 - 4 8 2 1 17 
Klebsiella.spp - 2 1 - 3 - 6 
Proteus .spp - - 2 3 1 - 6 
Enterococci - - 1 - 1 2 4 
Acinetobacter.spp - - 1 - - 2 3 
Candida.spp - - 2 1 - - 3 
Pseudomonas 
aeruginosa 1 - - - - 1 2 
CONS - - 1 - - - 1 
Staph.aureus - 1 - - - - 1 
Total 3 (6.9%) 
3 
(6.9%) 
12 
(27.9 %) 
12 
(27.9 %) 
7 
(16.2%) 
6 
(13.9%) 43 
 
The table above shows that out of 43 isolates majority of the isolates 
were from the 41-50 (27.9 %) and 51-60 age group (27.9 %) followed by 61-
70  (16.2%)and 71-90 (13.9%)age group. Least isolates were from the 20-30 
and 31-40 (6.9%) age group. 
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Table-25 Colony counts of isolates 
Isolates Colony count- CFU/ml Total isolates <10 2 10 2-10 4 10 4- 10 5 >10 5 
E.coli 5 6 3 3 17 
Klebsiella.spp 2 4 - - 6 
Proteus .spp - 3 2 1 6 
Enterococci - 2 1 1 4 
Acinetobacter.spp - 1 2 - 3 
Candida.spp 1 2 - - 3 
Pseudomonas 
aeruginosa - 1 1 - 2 
CONS - 1 - - 1 
Staph.aureus - 1 - - 1 
Total 9 20 9 5 43 
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 The table above shows that 5 patients (5%) out of 100 patients had 
significant colony count (>10 5 CFU/ml). Majority of the patients had colony 
counts inbetween 10 2-10 4 CFU/ml (20 %). 
 
 
 
Table-26 Daywise analysis of significant colony count (>105cfu/ml) 
Isolates 3
rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
Total
 
E.coli 1 - 2 3 
Proteus .spp 1 -  1 
Enterococci 1 -  1 
Total 3(3%) 0 2(2%) 5(%) 
 
 Among the 100 patients only 5 (5%) patients had more than 105cfu/ml 
.Three patientson the third day and two (2%)patients on both third day and 
seventh day had significant colony count. 
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Table-27 Antibiogram of isolates – Cystoscopy -Bacterial isolates 
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Table-27 –A   Gram negative bacilli –ENTEROBACTERIACEAE 
NON-ENTEROBACTERIACEAE 
 
 
Isolates 
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Table-27 –B Gram positive cocci 
S.aureus 
 
Isolat
es 
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Enterococci  
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Table-2 –C  Sensitivity pattern of fungal isolates 
Isolate Total isolate 
Fluconazole Voriconazole 
S R S R 
Candida albicans 2 2 0 2 0 
Candida tropicalis 1 1 0 1 0 
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URODYNAMIC STUDY 
TABLE-28 Age and Sex wise distribution of samples 
 
 Above table shows that among the 100 patients underwent urodynamic 
study 54 of them were male patients (54%) and 46 of them were female 
patients (46%). Majority of the patients were from 41-50 (29%) age group 
followed by 51-60 age group (23%), 61-70 (20%) age group followed by 31-
40 (14%)age group. Least number of patients from 21-30( 4%) age group. 
Age Male Female Total(male+female) 
21-30 2(3.7%) 2(4.3%) 4(4%) 
31-40 7(12.9 %) 7(15.2%) 14(14%) 
41-50 17(31.4 %) 12(26%) 29(29%) 
51-60 9( 16.6%) 14(30.4%) 23(23%) 
61-70 12( 22.2%) 8(17.3%) 20(20%) 
71-90 7( 12.9%) 3(6.5%) 10(10%) 
Total 54(54%) 46(46%) 100 
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TABLE-29 Age and Sex wise distribution of culture positive patients – 
Age 
Male Female Total Culture +ve patients Total 
Culture
+ve% 
Total 
No. of 
patient
s 
Culture 
+ves 
patients
Total 
No. of 
patient
s 
Culture 
+ves 
patients 
No. of 
patien
ts 
Cultur
e +ve 
patient
s 
21-30 2 0 2 1 (50%) 4 1 25 
31-40 7 2 (28.5%) 7 
2 
(28.5%) 14 4 28.57 
41-50 17 1 (5.88%) 12 1 (5.8%) 29 2 6.90 
51-60 9 3 (33.3%) 14 
2 
(14.2%) 23 6 21.74 
61-70 12 1 (8.3%) 8 
1 
(12.5%) 20 2 10 
71-90 7 1 (14.2%) 3 0 10 1 10 
Total 54 8 (14.8%) 46 
7 
(15.2%) 100 15 15 
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 Above table shows that 15 (15%) patients were culture positive among 
100 patients underwent urodynamic study. Among these 15 culture positives 8 
(14.8%) were males and 7 (15.2%) were females. 
 
 
 
Table-25     Correlation between pyuria, Gram’s stain and culture 
Gram’s stain 
showing 
bacteria 
Growth 
on culture
Wet mount 
No. of pus cells/HPF 
Total 
samples- 
300 0-3/HPF 3-5/HPF >5/HPF 
Absent 
Absent 273 11 - 284(94.6%)
Present - 9 2 11(3.6%) 
Present Present - 1 4 5(1.6%) 
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 Among 300 samples only 5 (1.6%) samples showed bacteria on Gram 
stain and the remaining 295 samples does not show any bacteria on Gram 
stain. Among the 295 Gram stain ne samples 284 samples (94.6%) were 
culture negative and 11 sample was culture positive. Among the 284 samples 
273 samples had 0-3 pus cells and 11samples (3.6%)had 3-5 pus cells per high 
power field. Among the 11samples 2 had > 5 pus cells  and 9 had 3-5 pus cells 
per high power field. All the 5 samples showing bacteria on Gram stain were 
culture positive. Among these 5 samples 1 had 3-5 pus cells and 4 samples had 
> 5 pus cell per high power field.  
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Table-18 Distribution of Culture +ve and Culture –ve patients 
Gender No. of pts
Culture +ve Pts 
Culture -ve 
Pts 
No.of Pts 
with 
Single 
isolate 
No.of Pts 
with 
Mixed  
isolates(2 
isolates) 
Total 
No.ofCul
ture +ve 
Pts 
Male 54 7 1 8 46 
Female 46 5 2 7 39 
Total 100 12(12%) 3(3%) 15(15%) 85(85%) 
 
Among the total 100 patients 15(15%) patients were culture positive and 
patients 85(85%) were culture negative. Among the 15 culture patients 
12(12%) were culture positive for single organism on culture and 3 (3%) were 
culture positive for mixed organisms. 
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Table-19 Daywise analysis for Culture +ve for single organism 
 No. of Culture  +ve pts 
Culture +ve for single organism 
3rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
Male 7 5 1 1 
Female 5 3 1 1 
Total 12 8(66.66%) 2(16.66%) 2(16.66%) 
 
 Among the 12 culture positive patients for single isolates 7 patients 
were from males and 5 patients were from females. Majority of the patients 
yielded growth on the third day. 8 (66.66%) patients yielded growth on third 
day, 2(16.66%) patients yielded growth on seventh day and 2 (16.66%)patients 
yielded growth on both third and seventh day. 
 
Table-20 Daywise analysis for Culture +ve for mixed organism 
 
No. of 
Culture 
+ve pts 
No. of Culture +ve Pts for mixed organisms (2 
isolates) 
3rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
Male 1 1 0 0 
Female 2 1 1 0 
Total 3 2(66.66%) 1(33.33%) 0 
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 Among the 3 culture positive patients for mixed isolates 1 patient were 
from males and 2 patients were from females. 2 (66.66%) patients yielded 
growth on third day, 1(33.33%) patient yielded growth on seventh day. None 
of patients yielded mixed growth on both third and seventh day. 
 
Table- 21 Day wise distribution of single isolates 
Isolates Total 3
rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
E.coli 6 4 1 1 
Klebsiella.spp 3 2 - 1 
Proteus .spp 2 1 1 - 
Enterococci 1 1 - - 
Total 12 8(66.66%) 2(16.66%) 2(16.66%) 
 
 Majority of them were isolated on third day i.e 8 out of 12(66.66%), 2 
were isolated on seventh day (16.66%) and 2 were (16.66%) isolated on both 
third and seventh day. 
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Table-22 Day wise distribution of mixed isolates 
Mixed isolates 
Culture +ve for mixed organism(2 isolates) 
3rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
E.coli+Proteusspp 1 - 0 
Klebsiellaspp +CONS 1 - 0 
E.coli+C.albicans - 1 0 
 
Out of three patients two patients yielded two isolates on third day, 1 patient 
yielded two isolates on seventh day and none of the patients yielded mixed 
isolates on both third and seventh day. 
 
Table- 23 Day wise distribution of single and mixed isolates 
Isolates 3
rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve Total 
E.coli 5 2 1 8(44.4%) 
Klebsiella.spp 3  1 4(22.2%) 
Proteus .spp 2 1 - 3(16.6%) 
Enterococci 1 - - 1(5.5%) 
CONS 1 - - 1(5.5%) 
Candida. Spp - 1 - 1(5.5%) 
Total 12(66.66%) 4(22.22%) 2(11.11%) 18 
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 The table above shows that among the total 18 isolates 12(66.66%) were 
isolated on the third day, 4 (22.22%)were isolated on the seventh day and 2 
(11.11%) were isolated on both third and seventh day.  
 
 Majority of the isolates were E.coli (44.4%) followed by Klebsiella 
.spp( 22.2%), Proteus .spp ( 16.6%), Enterococci (5.5%),  Candida. Spp(5.5%) 
and CONS( 5.5%). 
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Table -28 Distribution of isolates among different age groups 
Isolates 
Age group 
Total 
isolate21-
30 31-40 41-50 51-60 61-70 71-90 
E.coli - 3 1 3 0 1 8 
Klebsiella.spp - 1 1 - 2 - 4 
Proteus .spp - - 1 2 - - 3 
Enterococci - - - 1 - - 1 
Candida.spp - - - 1 - - 1 
CONS - 1 - - - - 1 
Total - 5(27.7%) 3(16.6%) 7(38.8%) 2(11.1%) 1(5.5%) 18 
 
 The above table shows tha1t out of 18 isolates majority of isolates were 
from the 50-60 age group (38.8%) followed by 31-40 age group (27.7 %). 
Predominant isolates were E.coli followed by Klebsiella .spp. 
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Table-29 Colony counts of isolates 
Isolates 
Colony count Total 
isolates <10 2 10 2-10 4 10 4- 10 5 >10 5 
E.coli 1 3 2 2 8 
Klebsiella.spp - 2 1 1 4 
Proteus .spp - - 2 1 3 
Enterococci - 1 - - 1 
Candida.spp 1 - - - 1 
CONS - 1 - - 1 
Total 2 9 5 4 18 
 
 The table above shows that 4 patients (4%) out of 100 patients had 
significant colony count (>10 5 CFU/ml). Majority of the patients had colony 
counts inbetween 10 2-10 4 CFU/ml ( 9%). 
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Table-26 Daywise analysis of significant colony count (>105cfu/ml) 
Isolates 3
rdday+ve 
7th day-ve 
3rd day-ve 
7thday+ve 
3rdday+ve 
7thday+ve 
Total
 
E.coli 1 - 1 2 
Proteus .spp - 1 - 1 
Klebsiella.spp 1 - - 1 
Total 2(2%) 1(1%) 1(1%) 4(4%)
 
 Among the 100 patients only 4 (4%) patients had more than 
105cfu/ml.One patient on the third day and one (1%)patients on both third day 
and seventh day had significant colony count. 
 
ANTIBIOGRAM OF ISOLATES – URODYNAMIC STUDY 
Table-30(A)Bacterial isolates  -Gram negative bacilli 
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Table-30 (B) Gram positive cocci- Enterococci. spp 
 
Isolat
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NF PEN NX HLG CIP AMPI 
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Table-30(C) Fungal isolates 
Isolate Total isolate 
Fluconazole Voriconazole 
S R S R 
Candida 
albicans 1 1 0 1 0 
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MIC OF ANTIBIOTICS TESTED 
Table-31(A) MIC of Vancomycin to Staphylococcus aureus 
Number of isolates tested-1 
 Sensitive Intermediate Resistant 
Antibiotic 
concentration µg/ml <2 4-8 8-16 
Vancomycin 1 - - 
 
The isolate tested was within the MIC sensitivity range.  
 
Table-31(B) MIC of Fluconazole and voriconazole to  
Candida albicansNumber of isolates tested-1 
 
 
Fluconazole Itraconazole Voriconazole 
S SDD R S SDD R S SDD R 
Antibiotic 
concentration 
µg/ml 
≤8 16-32 ≥64 ≤0.125
0.25-
0.5 ≥1 ≤1 2 ≥4 
Candida spp 2 - - 0.0625   0.25 - - 
 
The isolate tested was within the MIC sensitivity range.  
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CYSTOSCOPY AND URODYNAMIC STUDY 
Table-31 Gender wise distribution of samples 
Procedure Number of Males 
Number of 
Females Total patients 
Cystoscopy 55 45 100 
Urodynamic study 54 46 100 
Total 109(54.5%) 89(44.5%) 200 
 
Among 200 patients 109 were from males and 89 were from females. 
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Table-32 Culture positive and negatives 
Procedure 
Number of 
Culture +ve 
patients 
Number of 
Culture -ve 
patients 
Total 
patients 
Cystoscopy 38 62 100 
Urodynamic study 15 85 100 
Total 53(26.5%) 147(73.5%) 200 
 
 53(26.5%) patients were culture positive and 147(73.5%) patients were 
culture negative. 
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TABLE-33 Single and mixed isolates 
Procedure 
No of cuture 
+ve pts with 
Single 
isolate 
No of cuture 
+ve pts with 
Mixed 
(Two)isolate 
Total No of 
cuture +ve pts 
Cystoscopy 33 5 38 
Urodynamic study 12 3 15 
Total 45(84.9%) 8(15.09%) 53 
 
 Among the 53 culture positive 48 patients had single isolates and 8 
patients had mixed isolates. 
 
Table-34 Distribution of isolates 
Isolates Cystoscopy Urodynamic study Total 
E.coli 17 8 25 (40.9%) 
Klebsiella.spp 6 4 10 (16.3%) 
Proteus .spp 6 3 9 (14.06%) 
Enterococci 4 1 5 (7.81%) 
Acinetobacter.spp 3 0 3 (4.68%) 
Candida.albicans 2 1 3 (4.68%) 
Candida.tropicalis 1 0 1 (1.56%) 
Pseudomonas 
aeruginosa 2 0 2 (3.12%) 
CONS 1 1 2 (3.12%) 
Staph.aureus 1 0 2 (3.12%) 
Total 43(70.49%) 18(29.5%) 61 
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Table-35 No. of pts with Significant colony count (>105 CFU/ml) 
Procedure No of patients E.coli 
Proteus 
spp Klebsiella.spp Total% 
Cystoscopy 100 3 2 - 5% 
Urodynamic 
study 100 2 1 1 4% 
Total 200 5 3 1 4.5% 
 
 In cystoscopic study 5(5%) patients had significant colony count.In 
urodynamic study 4(4%) patients had significant colony count. 
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Table-36 ESBL producers 
Procedure E.coli [25] Klebsiellaspp[10] Proteus spp[9] 
Cystoscopy 2  1 1 
Urodynamic study 1 1 - 
Total 3(12%) 2(20%) 1(11.11%) 
 
TABLE-37 omp T GENE IN E.coliisolates with >10 5 CFU/ml 
GENE PRIMER SEQUENCES 
AMPLICON 
SIZE IN 
BASE 
PAIRS 
RESULT
ompT 5'-CACGCTCCACAAACCAAGTG-3 1120 Negative 
 
 Bright band was not seen on 1120 base region of ompT gene. 
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DISCUSSION 
 
 Various OP diagnostic, therapeutic procedures were carried out in our 
urology department, RGGGH. Of which cystoscopy and urodynamic 
procedures were commonly employed for various disease conditions. Nearly 
250 cases in cystoscopy every month and 15 cases every month were carried 
out in urology. 
 
 The ability to manipulate the urinary tract without the need for an open 
surgical incision differentiates urology from other disciplines. Such 
intervention may be required for diagnostic, therapeutic purposes or both. 
Manipulation of the urinary tract can result in significant injury. The patient 
should understand the proposed procedure and potential complications. A 
patient who is comfortable, informed, and assured will more likely cooperate 
and tolerate the procedure. [53] 
 
 Cystoscopic examinations are performed extensively for the diagnosis 
and management of various urological disorders.Urodynamic studies were 
extremely valuable in devising a therapy based on altered physiology of the 
lower urinary tract. However these invasive investigations may be associated 
with marked morbidity.The morbidity of these procedures has been studied 
only in the context of urinary tract infections. 
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 Urinary tract infection is the most common nosocomial infection, 
comprising about 35 % of such occurrences in both hospitals and nursing 
homes. In both types of institutions, UTIS are usually associated with devices 
intended to assist in the drainage of urine. In hospitals were the epidemiology 
has been investigated, 80 % or more of the nosocomial UTIS are related to the 
use of urethral catheters. Another 5 % to 10 % occur after genitourinary 
manipulations [54]. As a predisposing factorurological invasive 
proceduresaccount for up to 10% of the hospital acquired infections [55]. 
 
 In the present study 600 urine samples were collected from 200 patients 
attending Cystoscopy and Urodynamic study at Urology department, RGGGH, 
Chennai. 
 
 In theCystoscopic study conducted among 100 Patients 38 patients were 
culture positive 62 were patients were culture negative. Among these 38 
culture positives 21 (38.18%) were males and 17 (37.77%) were females. 
There was no significant difference in culture positives among male and 
females. Among the 21 culture positive males > 40 age group had higher 
culture positives (>37 %) than < 40 age groups (25%). Increased 
instrumentation, and prostatic hypertrophy account for bacteriuria in older age 
group in males [56,57]. 
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 Among 17 culture positive females extremes of age groups 18-30 
(100%) and 71-90 (50%) had higher culture positives than the age groups in 
between but the number of patients were very limited so more number of 
patients were needed to substantiate these results. During adolescence, the 
incidence of UTI significantly increases to 20% in young women, while 
remaining constant in young men (Sanford,1975) [56]. Increased 
instrumentation and incontinence account for bacteriuria in older age group in 
females [56,57]. 
 
 In the Urodynamic study conducted among 100 Patients 15 patients 
were culture positive and 85 patients were culture negative. Among the 15 
culture positive patients 8 (14.8%) were males and 7 (15.2%) were females. 
Similar to cystoscopic results there was no significant difference in culture 
positives among male and females. Among the 18-30 age group there were no 
culture positives in males but 50 % were culture positives in females.  
 
 In Cystoscopy study conducted  the older age group (>40) females were 
less culture positives (<15%) compared to younger age (<40) groups (>25%). 
Prevalence of UTI increases with age in females [58]. Although Harrariet al 
found that bacteriuria incidence higher in elderly, the difference was not 
satistically significant.[59] Association of acquiring infection with increasing 
age which was found before urodynamic study was not seen after post 
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urodynamic study. This finding is in agreement with others who found no 
significant association between advancing age and UTI after urodynamics. 
 
 Wet mount and Gram stained preparations were used for microscopy. 
Wet mount of uncentrifuged urine was done usually to find out the presence of 
pus cells, epithelial cells and microorganisms. Pyuria is highly sensitive 
indicator of UTI [60] but some considers it as poor predictor of infection [62]. It 
indicates only inflammation not always infection [61]. In our present study 
though all the samples showed pus cells only 40 (13.33%) samples and 
16(5.33%) samples were culture positive from 300 samples each of cystoscopy 
and urodynamic study respectively. So presence of pus cells may not be the 
reliable indicator of UTI.  
 
 In post cystoscopy procedure study 9 (22.5%) samples out of 40 
samples and 5 (31.25%) samples out of 16 samples from cystoscopy and 
urodynamic study respectively which  were showing bacteria on Grams stain 
smear also showed growth on culture with 5 samples and 2 samples having 
significant colony count from cystoscopy and urodynamic study respectively . 
In 31(77.5%) and 11(68.75%) no bacteria was seen on Gram stain smear in 
cystoscopy and urodynamic study respectively. They also showed growth on 
culture revealing low sensitivity of Gram stain compared to culture. 
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 More than 90% of microscopic bacteriuria was detected in 
uncentrifuged Gram stained urine with colony counts 10 5CFU/ml [63]. Others 
studies indicate that Gram stain is of low sensitivity in detecting UTI [64]. 
 
 In the cystoscopic study 43 isolates were grown from the 38 culture 
positive patients. Out of38 patients 33 patients yielded single isolate on culture 
and five patients yielded two isolates on culture.Most of the patients were 
culture positive on third day (28 out of 38 ) and they turn out to be culture 
negative on seventh day.  8 patients who were culture negative on third day 
were culture positive on seventh day. Third day culture positive samples 
turned out to be culture negative on seventh day indicating acute transient 
infection .Since it disappeared on the seventh day antibiotics was unnecessary. 
Third day culture negative samples turned out to be culture positive on seventh 
day may due unhygienic practices and since they are asymptomatic antibiotics 
need not to be administered and requested to give samples on tenth day.   
 
 And 2 (2%) patients out of 100 patients were culture positive on both 
third and seventh day with significant colony count >105 CFU/ml and one 
patient was symptomatic indicating significant persistent infection of these 
patients and they had underlying conditions such as diabetes and this 
symptomatic patient was treated with first line antibiotics  . With a cut-off 
level of >105 CFU/ml only 5 isolates could be classified as significant 
bacteriuria. Out of 100 patients only 5 patients  (5%)  had significant colony 
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count >10 5CFU/ml. Cystoscopy performed in the outpatient setting carries a 
risk of post-procedure UTI of between 2.7% and 4.5% [65]. This finding was 
similar to our study. 
 
 In our study, the most predominant urinary pathogen isolated from the 
post cystoscopy patients was E. coli (39.5%). This finding was similar to 
previous observations [66,67,74]. The other predominant pathogens were 
Klebsiellaspp(13.9%) and Proteus spp(13.9%).Other isolates were 
Acinetobacterspp(6.9%), Pseudomonas aeruginosa(4.6%), Enterococci 
(9.3%),S.aureus(2.32%), CONS (2.32%) and Candida spp(6.9%). 
 
 In the post procedure urodynamic study conducted, 18 isolates were 
grown from the 15 culture positive patients. Among these 15 patients 12 (12%) 
yielded single isolate on culture and 3(3%) patients yielded two isolates on 
culture. Most of the patients were culture positive on third day (10 out of 15 ) 
and they turn out to be culture negative on seventh  3 patients who were 
culture negative on third day were culture positive on seventh day. Third day 
culture positive samples turned out to be culture negative on seventh day 
indicating acute transient infection. Since it disappeared on the seventh day 
antibiotics was unnecessary Culture positive only on seventh day may be due 
to improper perineal toileting.Since they are asymptomatic antibiotics need not 
to be administered and requested to give samples on tenth day.    
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 And 2 (2%) patients were culture positive on both third and seventh day 
with significant colony count >105  CFU/ml indicating significant persistent 
infection. On post-test sampling 18 cultures were positive. With a cut-off level 
of >105 CFU/ml only 4 isolates could be classified as significant bacteriuria. 
Only 1 was symptomatic and this patient had diagnosed as neurogenic bladder. 
The remaining had no symptoms following the post urodynamic study. Thus 
the incidence of lower urinary tract infection was 4 % following diagnostic 
catheterization. We concluded that although bacteriuria is common after 
diagnostic catheterization, it is commonly asymptomatic. Out of 100 patients 
only 4(4%) patients had significant colony count >10 5CFU/ml in our study but 
higher rates of infection (7.5%) after urodynamic procedure were reported by 
Bergemanet al [68]. We have 5% of significant counts in post-cystoscopy and 
4% significant count in post-urodynamic study similar to the study by 
Allahmella et al.[78]We should also note that 5 patients from Urodynamic and 9 
patients from cystoscopy had counts inbetween 104-105CFU/ml. 
 
 In this study, the most predominant pathogen isolated from the post 
urodynamicswasE.coli (44.4%). The second predominant pathogen isolated in 
our study was Klebsiellaspp(22.2%) These finding were similar to previous 
observations [69]. Other isolates were Proteus spp(16.6%), Enterococci (5.5%), 
CONS (5.5%) and Candida spp(5.5%).  One member of Candida spp (Candida 
albicans )was isolated in our study. S. aureuswas not isolated in our study.  
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 E. coli, Proteus sppand Enterococci spp have been reported by 
Leblebicioglu et al[70] as the most frequently acquired bacterial pathogens . 
 
 Of the 25E. coli isolates tested in our post procedure study 58.8 % were 
resistant to ampicillin, 4 % were resistant to Amikacin, 64 % were resistant to 
Gentamycin, 20 % were resistant to Nitrofurantoin, 12 % were resistant to 
Norfloxacin and 12 % were resistant to Cefatoxime. Among these 3 were 
ESBL producers (12%). It showed low resistance to nitrofurantoin (20 %) may 
be due to less frequent prescription of these drugs and these reports were 
similar to reports by Biswas et al and Kauser et al [71,72]. Low level of 
resistance of Amikacin was observed in our study compared to other studies. 
But it showed high level of resistance to gentamycin in our study. In India 
aminoglycoside resistance ranges between 5[72] % to 36.1 % [73]. Low level of 
resistance of Norfloxacin was observed in our study similar to reports by 
Arjunanet al [75]. 
 
 There are many virulent genes associated with uropathogenicE. coli. We 
have tested one of the virulent gene ompT(outer membrane protein) for the E. 
coliwhether it is present in patients with significant colony  count and 
symptoms.Of the 25 E. coliisolates 5 isolates had colony count of 10 5 
CFU/ml were tested for the presence of ompT gene by conventional PCR 
method. None of these isolates showed positive band for the ompT gene. 
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E. coli isolates obtained after bladder instrumentaion usually lacks virulence 
factors was reported by Zdziarski et al similar to our results. Asymptomatic 
bacteriuria appear to be lose their ability to express functional virulence 
associated genes. 
 
 The common pathogen isolated next to E. coli was Klebsiellasppin our 
study and it is the same in most of the Indian studies. All the 10 isolates 
exhibit high level of resistance to ampicillin (80%) and gentamycin (40%) 
compared to other drugs as in other studies [71.76]. It showed low level of 
resistance to amikacin (20%), nitrofurantoin (10%), norfloxacin (20%) and 
cefotaxime (20%) compared to other studies [71,76]. Among the 10 isolates 
2(20%) were ESBLproducers. 
 
 Of the 9 Proteus spp isolates all are sensitive to amikacin whereas 
55.55% of the isolates showed resistance to gentamycin. It showed high 
resistance to ampicillin (77.77%). Resistance pattern of other drugs were 
cefotaxime (11.11%), nitrofurantoin (33.33%) and norfloxacin (11.11%). 
Among the 9  proteus isolates 1 was a ESBL producer. 
 
 Of the non Enterobactericeaegroup 2 Pseudomonas aeruginosaand 3 
Acinetobactersppwere isolated in our postcystoscopy study and not in 
urodynamic study. Pseudomonas aeruginosashowed 100 % resistance to 
ciprofloxacin similar to the study by Bhargavi et al [77]. These 2 isolates were 
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sensitive to amikacin, norfloxacin, ceftazidime and piperacillintazobactum. 
High resistance were observed for these drugs in other studies[76,77]. Three 
Acinetobactersppwere isolated in our study with 33.33% resistance to 
gentamycin and ciprofloxacin. They were all sensitive to amikacin, 
norfloxacin, ceftazidime and piperacillintazobactum. 
 
 Enterococci spp constitutes 7.8% of the total isolates and it was the 
fourth commonest pathogen isolated in our study.  Four were E. faecium and  
1  was E. faecalis.  It showed 80% resistance to penicillin and ciprofloxacin , 
60% resistance to ampicillin and 40 % resistance to nitrofurantoin and 
norfloxacin. 28.57%  resitance was reported for norfloxacin in other study [77]. 
The resistant pattern for nitrofurantion was similar to Mahesh et al study [77]. 
 
 One isolate of CONS (3.1%) and two isolates of S. aureus (1.5%) were 
isolated in our study. They were all resistant to penicillin (100%) and sensitive 
to all other drugs tested except the S.aureus was methicillin resistant. MIC 
values of vancomycin to S.aureus was within the sensitivity range. 
 
 Candiduria is an increasingly common finding in hospitalized patients 
and most of the patients were asymptomatic as there are no associated signs 
and symptoms. Four isolates of Candida spp (6.25%) were isolated in our 
study. Three were C. albicansand 1 was C.tropicalisin our study and they were 
all sensitive to fluconazole and voriconazole and their MIC values were within 
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their sensitivity range.C.tropicalis were second most commonly isolated next 
to C. albicans. All these isolates had insignificant colony counts and were 
from female patients having Diabetes. Comorbid conditions associated with 
candiduria were surgical procedures, diabetes mellitus, urologic abnormality, 
female sex, invasive genitourinary devices and antimicrobial use. 
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SUMMARY 
 
 A total of 100 patients each undergoing for cystoscopy and urodynamic 
study were evaluated for UTI. Three samples were collected from each patient. 
The samples which were culture positive on the day of the procedure were 
subsequently excluded from the study.  
 
 Culture positivity rate is marginally higher in males than females. In 
cystoscopy culture positivity rate was higher in the above 40 age groups and in 
urodynamics extremes of age group had higher culture positivity rate. 
 
 Cultures of samples were considered the reliable method when 
compared to wet mount and Gram stain. E.coli was the commonest pathogen 
and second commonest pathogen was Klebsiella.spp isolated in our post 
procedure study similar to other studies. Others were Enterococci spp, Proteus 
spp, P.aeruginosa, Acinetobacterspp, CONSandS.aureus .Candida.Sppwas 
isolated with insignificant colony counts. 
 
 Semiquantitative method was employed to detect colony counts. With a 
cut off level >105count as significant colony count only five patients from post 
cystoscopy and our from post urodynamic procedure hadsignificant colony 
counts and only two patients were symptomatic. So the incidence of UTI was 
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5% and 4% for post cystoscopy and post urodynamic procedure respectively. 
Others had transient asymptomatic bacteriuria. 
 
 The commonest isolate E. coliwith significant count was not associated 
with the virulent ompT gene one of the markers for urosepsis. 
 
 All isolates exhibited high level resistance to ampicillin. Five ESBL 
producers were identified. No multiple drugs resistant isolates was detected in 
our study. 
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CONCLUSION 
 
 Both cystoscopy and urodynamic study are invasive procedures since 
they are done by instrumentation and catheterization respectively and they are 
considered as a predisposing factor for UTI in patients undergoing these 
procedures. 
 
 Semi quantitative culture is a reliable method for detecting 
asymptomatic bacteriuria and defining urinary tract infections. The 
predominant isolates in post cystoscopy and urodynamic studies were E.coli 
and Klebsiella spp. 
 
 There is statistical correlation that the rate of infection in post 
cystoscopy and urodynamic study is marginally higher in the males than the 
females ( P value < 0.05)  Out of 200 patients significant persistent infection 
was seen in two patients and it was associated with other underlying conditions 
like diabetes and neurogenic bladder. Statistical association of underlying 
conditions with infection rate was found to be significant (P value < 0.05). No 
association of virulent gene ompT with E. Coliwith significant counts. 
 
 Both Urodynamic and cystoscopy are safe and well tolerated OP 
diagnostic procedures, though there is a minimal percentage of transient 
infection and unnecessary antibiotics need not to be administered. 
 
 
 
 
Appendix 
  
APPENDIX – I 
 
ABBREVIATIONS 
  
 
ATCC   - American Type Culture Collections 
ESBL   - Extended spectrum Beta Lactamases 
CFU   - Colony Forming Units 
CLSI   - Clinical & Laboratory Standards Institute 
CNF1                 - Colonizing Necrotising Factor 
DMSO            - Dimethyl Sulfoxide 
MIC                  - Minimum Inhibitory Concentration 
OmpT            - Outer Membrane Protein 
RPMI              - Rose Well Park Memorial Institute 
SDA                - Sabouraud’s Dextrose Agar 
PCR                 - Polymerase Chain Reaction 
PVR             - Post Void Residual Volume 
PBS                 - Phosphate Buffer Solution 
UTI                 - Urinary Tract Infection 
 
  
APPENDIX -II 
 
 
A. MEDIA USED 
1. CLED Agar 
Peptone     4g 
Tryptone                         4g 
Meat extract powder                                   3g 
L-Cystine                                                     0.128g 
Distilled Water    1 Ltr 
Agar     15g 
Bromothymol blue                        0.2g 
10% Lactose Solution    100ml 
Suspend the ingredients in the water, bring to the boil to dissolve, sterilize at 
121◦C for 15 minutes and mix well before pouring. 
 
2.Mueller- Hinton Agar 
Beef Infusion 300ml 
CaeseinHydrolysate 17.5g 
Starch 1.5g 
Agar Log 
Distilled Water Lltr 
Ph = 7.4 
Sterilise By Autoclaving At 121°C For 20 Mins 
3.Sabouraud Dextrose Agar with Antibiotics  
Composition of Sabouraud Dextrose Agar  
Dextrose : 20 gm   
Peptone : 10 gm  
Agar : 20 gm  
       Distilled Water : 1000 ml  
       Final pH : 6.9  
            The ingredients are dissolved by boiling.Chloramphenicol(50mg/lit) and 
Cycloheximide(500mg/lit) was added .Chloramphenicol was dissolved in 10 ml of 95% 
ethanol and added to boiling medium. Cycloheximide was dissolved in 10 ml of acetone 
and added to the boiling medium. Autoclave at 121°C for 15 minutes, Dispense in sterile 
tubes and allow to cool in slanted position. 
 
4.CORNMEAL AGAR MEDIUM: 
 Cornmeal    : 8gm 
Agar              : 4gm 
Tween 80(1%): 2ml 
Distilled water : 200ml 
                    Heat cornmeal and water at 60ºC for 1 hour and filter through filter paper.Add 
distilled water to make it 200ml and then add agar.Tween 80 is then added.Autoclave it at 
121ºC for 15 mins. 
5.YEAST NITROGEN BASE MEDIUM 
Part A :Agar 40gms/lit 
Part B :Yeast nitrogen base 6.7gms/lit 
40 grams of part A  media is suspended in 900 ml of distilled water. Heat to boiling to 
dissolve the medium completely.Autoclave at 121º C for 12 minutes.Cool to 50° C and 
mixed with sterile part B solution aseptically. 
6.CHROMAGAR CANDIDA MEDIUM: 
Ingredients                                           Gms/L 
Peptone                                                     15.00 
Yeast extract                                              4.00 
Dipotassium hydrogen phosphate           1.00 
Chromogenic mixture                              7.22 
Chloramphenicol                                      0.50 
Agar                                                         15.00 
Final pH: 6.3. 
       42.72 grams of media is suspended in 1000 ml of distilled water.Heat to boiling to 
dissolve  the  medium  completely. Donot  autoclave. Cool to 50° C and pour in sterile 
petridish. 
7.MUELLER HINTON AGAR : 
Ingredients                                              Gms / Litre 
Beef extract                                                   3.000 
Casein acid hydrolysate                                17.500 
Starch                                                            1.500  
Agar                                                       17.000 
Final pH (at 25°C)  7.3±0.2 
38grams of media is suspended in 1000 ml of distilled water.  Add 20gm of glucose(2%) 
and  methylene blue(0.5µg/ml) is added.Dissolve themedium completely. Dispense and 
sterilize by autoclaving at 115-121°C for 10 minutes. DO NOT OVERHEAT. 
 
8.RPMI 1640 MEDIUM[With glutamine and without bicarbonate] 
     Obtained commercialy as a dehydrated powder.Suspend 8.4gms of media in 900ml of 
sterile distilled water.Stirit  to completely dissolve the medium donotheat.Sterilize the 
medium by filtration.Final pH=7.0. 
  
B. MEDIA REQUIRED FOR BIOCHEMICAL IDENTIFICATION 
1. Oxidase Reagent 
Tetra Methyl P-PhenyleneDiamineDihyrochloride- 1% Aqueous Solution. 
2. Catalase 
3% Hydrogen Peroxide 
3.Kovac's Reagent 
Amyl OrIsoamyl Alcohol 150ml Para Dimethyl Amino Benzaldehyde Log 
Concentrated Hydrochloric Acid 50ml 
Dissolve The Aldehyde In The Alcohol And Slowly Add The Acid. Prepare In Small 
Quantities And Store In The Refrigerator. Shake Gently Before Use. 
4.Christensen's Urease Test Medium 
 Peptone  Lg 
 Sodium Chloride  5g 
 Dipotassium Hydrogen Phosphate  2g 
 Phenol Red  6ml 
 Agar  20g 
 Distilled Water  1 Ltr 
 10% Sterile Solution Of Glucose  10ml 
 Sterile 20% Urea Solution  100ml 
Sterilize The Glucose And Urea Solutions By Filtration. Prepare The Basal Medium 
Without Glucose And Urea, Adjust To Ph 6.8-6.9 And Sterilize By Autoclaving In A Flask 
At 121°C For 30min. Cool To About 50°C, Add The Glucose & Urea, And Tube The 
Medium As Slopes. 
 
 
5.Simmon's Citrate Medium 
Koser's Medium   1 Ltr 
Agar   20 G 
Bromothymol Blue 0.2%      40ml  
Dispense, Autoclave At 121°C For 15 Min And Allow To Set As Slopes 
 
6.Triple Sugar Iron Medium 
Beef Extract   3g 
Yeast Extract   3g 
Peptone   20g 
Glucose   Lg 
Lactose   10 G 
Sucrose   L0g 
Ferric Citrate   0.3g 
Sodium Chloride   5g 
S OdumThiosulphate   0.3g 
Agar   12g 
Phenol Red 0.2% Solution   12ml 
Distilled Water   1 Ltr 
 
 Heat To Dissolve The Solids, Add The Indicator Solution, Mix And Tube. Sterilize 
At 121°C For 15 Min And Cool To Form Slopes With Deep Butts. 
 
7. Glucose Phosphate Broth 
Peptone   5g 
Dipotassium Hydrogen Phosphate   5g 
Water   1 Ltr 
Glucose 10% Solution   50ml 
 Dissolve The Peptone And Phosphate And Adjust The Ph To 7.6. Filter Dispense In 
5ml Amounts And Sterilize At 121°C For 15min. Sterilize The Glucose Solution By 
Filtration And Add 0.25ml To Each Tube. 
8. Peptone Water Fermentation Test Medium. 
 To The Basal Medium Of Peptone Water, Add Sterilised Sugars Of 1% Indicator 
Bromothymol Blue With Durham's Tube. Basal Medium Peptone Water Sugar Solutions: 
Sugar       1ml 
Dislilled Water     100ml  
Ph = 7.6. 
 
9.Potassium Nitrate Broth 
Potassium Nitrate (Kno3) 0.2gm 
Peptone 5.0gm 
Distilled Water 100ml 
The Above Ingredients Were Mixed And Transferred Into Tubes In 5 Ml 
Amount And Autoclaved. 
 
10.Phenyl Alanine Deaminase Test 
Yeast Extract 3g 
Dl-Phenylalamine 2 g  
Disodium Hydrogen Phosphate L g  
Sodium Chloride 5 g  
Agar 12g 
Distilled Water 1 Lr 
Ph 7.4 
Distributed In Tubes And Sterilized By Autoclaving At 121° C 
For 1 5 
Minutes, Allowed To Solidify As Long Slopes. 
 
11.POTASSIUM HYDROXIDE MOUNTS  
It is prepared from the following ingredients  
Potassium hydroxide : 20 gms 
Glycerol : 10 ml  
Distilled water : 80 ml  
         To a solution of 20% KOH, 10% Glycerol is added to prevent drying.Mix ingredients 
and store at room temperature. For 40% KOH 40gms of potassium hydroxide is added. 
 
12.LACTOPHENOL COTTON BLUE STAIN  
The lacto phenol cotton blue (LPCB) is used to study the morphological features of the 
fungal isolates.   
It contains the following ingredients:  
Melted phenol : 20 ml  
Lactic acid : 20 ml  
Glycerol : 40 ml  
         Cotton blue : 0.05 gm  
         Distilled water : 20 ml  
 Mix all the reagents properly and dissolve 0.05 g of cotton blue stain in the distilled 
water before mixing with the remaining reagents. The phenol acts as disinfectant, lactic 
acid preserves the morphology of the fungi and glycerol is hygroscopic agent which 
prevents drying. The cotton blue stains the outer wall of the fungus. Tease out of a 
fragment of the culture on a glass slide in a drop of LCB using two teasing needles. Put of 
a coverslip and examine under the microscope. If the plane LCB is used the edges of the 
coverslip can be sealed with nail polish to keep it for longer period of time.  
  
 13. Sugar Fermentation Medium 
Peptone 15g 
Andrade's Indicator 10 Ml 
Sugar To Be Tested 20g 
Water 1 Litre 
Andrade's Indicator Is Prepared From 0.5% Aqueous Acid Fuchsin to 
Which Sufficient 1m Sodium Hydroxide Has Been Added to turn the colour of 
theSolution Yellow. 
 
Dissolve The Peptone And Andrade's Indicator In 1 Litre Of Water And Add 20g Of 
The Sugar; Sugars To Be Tested Generally Include Glucose, Sucrose, Lactose And 
Maltose. Distribute 3ml Amounts In Standard Test Tubes Containing An Inverted 
Durham Tube. Sterilize By Steaming At 100 Degree C For 30 Min On 3 Consecutive 
Days. 
 
  
 
 
 
 
 
Annexure 
  
ANNEXURE-1 
PROFORMA 
 
 Name :                                                                       IP no: 
 Age:                                                                           Ward:      
 Sex: 
 Occupation: 
 Address: 
Presenting complaints: 
o High grade fever- 
o Chills: 
o Lower abdominal pain 
 Urinary incontinence 
 Urinary urgency 
 Urinary frequency 
Past history:  
H/O of trauma 
Personal history: 
• Alcohol intake: 
• Cigarette smoking: 
Associated immunocompromised state: 
Physical examination: 
UDS findings: 
Cystoscopy findings: 
 
CT scan findings/USG: 
 
Provisional diagnosis: 
Laboratory evaluation: 
Biochemical parameters: 
 plasma glucose levels 
  Blood urea 
 Creatinine 
Microbiological investigation: 
Sample collected: 
• Urine 
Direct examination: 
Gram’stain: 
 KOH mount: 
Bacterial Culture: 
Sheep Blood agar 
CLED agar 
Fungal culture: 
 SDA with antibiotics 
 CHROMagar 
Isolate identified in urinesample: 
 
Antibacterial susceptibility pattern: 
 
Antifungal susceptibility pattern: 
  
  
ANNEXURE-2 
PATIENT CONSENT FORM 
 
STUDY TITLE: 
A study on “Urinary bacterial and fungal isolates and their antimicrobial 
susceptibility pattern from patients undergoing invasive urological OP 
diagnostic procedures incuding Cystoscopy and Urodynamic study” 
 
I…………………………………………, hereby give consent to participate in 
the study conducted by Dr.M.Viji, Post graduate at Institute of Microbiology, 
Madras Medical College, Chennai and to use my personal clinical data and the 
result of investigations for the purpose of analysis and to study the nature of 
the disease, I also give consent to give my urine sample for further 
investigations. I also learn that there is no additional risk in this study. I also 
give my consent for my investigator to publish the data in any forum or journal  
  
Signature/ Thumb impression           Place:                           
Of the patient/ relative 
    Date: 
Patient Name & Address: 
 
 
Signature of the investigator: 
Signature of the guide: 
 
 
 
ANNEXURE – IV    -  MASTER CHART CYSTOSCOPY 
 
  
  
 
 
  
MASTER CHART - URODYNAMIC STUDY 
 
 
  
 
 
 
 
 
 
 
 KEY TO MASTER CHART 
 
Ak  -  Amikacin 
Gm   - Gentamycin 
Nf  -  Nitrofurantoin 
Nx  - Norfloxacin  
Ctx     - Cefotaxime 
Amp  - Ampicillin 
Cz  - Ceftazidime 
Pt  - PiperacillinTazobactum 
Hlg  - High level gentamycin 
Flu  - Flucanazole 
Vor  - Voricanazole 
Ery  -  Erythromycin 
CX  -  Cefoxitin 
Cotri  - Cotrimoxazole 
Pen  -  Penicillin 
Cip  -  Ciprofloxacin 
S  - Sensitive 
R  - Resistant  
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